<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
    <channel>
        <title>Journal of Molecular Medicine via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'Journal of Molecular Medicine' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=Journal+of+Molecular+Medicine&t=Journal+of+Molecular+Medicine&s=Search&f=source]]></link>
        <lastBuildDate>Thu, 09 Feb 2012 16:56:46 +0100</lastBuildDate>
        <item>
            <title>The E3 ubiquitin ligase TRIM11 mediates the degradation of congenital central hypoventilation syndrome-associated polyalanine-expanded PHOX2B</title>
            <link>http://www.medworm.com/index.php?rid=5673924&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy602171721091612%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Expansions of a polyalanine (polyA) stretch in the coding region of the PHOX2B gene cause congenital central hypoventilation syndrome (CCHS), a neurocristopathy characterized by the absence of adequate
 control of autonomic breathing. Expansion of polyA in PHOX2B leads to protein misfolding and accumulation into inclusions.
 The mechanisms that regulate mutant protein degradation and turnover have been poorly elucidated. Here, we investigate the
 regulation of degradation of wild-type and polyA-expanded PHOX2B. We show that expanded PHOX2B is targeted for degradation
 through the ubiquitin–proteasome system, resulting in lowered levels of the mutant protein relative to its wild-type counterpart.
 Moreover, we show that mutant PHOX2B forms ubiquitin-positive inclusions...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5673924</comments>
            <pubDate>Fri, 03 Feb 2012 17:52:37 +0100</pubDate>
            <guid isPermaLink="false">5673924</guid>        </item>
        <item>
            <title>microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis</title>
            <link>http://www.medworm.com/index.php?rid=5673925&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7g0w8532212044p4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Atherosclerosis has been established as a chronic inflammatory disease of the vessel wall. Among the mononuclear cell types
 recruited to the lesions, specialized dendritic cells (DCs) have gained increasing attention, and their secretory products
 and interactions shape the progression of atherosclerotic plaques. The regulation of DC functions by microRNAs (miRNAs) may
 thus be of primary importance in disease. We here systematically summarize the biogenesis and functions of miRNAs and provide
 an overview of miRNAs in DCs, their targets, and potential implications for atherosclerosis, with a particular focus on the
 best characterized miRNAs in DCs, namely, miR-155 and miR-146. MiRNA functions in DCs range from regulation of lipid uptake
 to cytokine production and T ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5673925</comments>
            <pubDate>Fri, 03 Feb 2012 17:52:36 +0100</pubDate>
            <guid isPermaLink="false">5673925</guid>        </item>
        <item>
            <title>Structural insights into a human anti-IFN antibody exerting therapeutic potential for systemic lupus erythematosus</title>
            <link>http://www.medworm.com/index.php?rid=5673926&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe2q1k3772h33623v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Increasing evidences suggest that the type I interferon α (IFNα) plays a critical role in the etiopathogenesis of systemic
 lupus erythematosus (SLE), which makes it a promising therapeutic target for the treatment of the disease. By screening a
 large size non-immune human antibody library, we have developed a human single-chain antibody (ScFv) AIFNα1bScFv01 and corresponding
 whole antibody AIFNα1bIgG01 to human interferon α1b (IFNα1b) with high specificity and high affinity. The IgG antibody could
 down-regulate the expression of ISG15 and IFIT-1 induced by either recombinant IFNα1b or naïve IFNα from SLE patients’ sera, and reduced total serum IgG and IgM antibodies
 level in a pristane-primed lupus-like mouse model. The crystal structure of AIFNα1bScFv0...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5673926</comments>
            <pubDate>Fri, 03 Feb 2012 17:52:35 +0100</pubDate>
            <guid isPermaLink="false">5673926</guid>        </item>
        <item>
            <title>Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5643834&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh42r00u547n14266%2F</link>
            <description>In conclusion, srVSV is a promising platform for virotherapeutic approaches and also for VSV-based vector vaccines, combining
 improved safety with an increased coding capacity for therapeutic transgenes, potentially allowing for multipronged approaches.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00109-012-0863-6Authors
		Alexander Muik, Georg-Speyer-Haus, 60596 Frankfurt am Main, GermanyCatherine Dold, Institute for Virology, Innsbruck Medical University, Fritz-Pregl-Str. 3, A-6020 Innsbruck, AustriaYvonne Geiß, Georg-Speyer-Haus, 60596 Frankfurt am Main, GermanyAndreas Volk, Georg-Speyer-Haus, 60596 Frankfurt am Main, GermanyMarina Werbizki, Georg-Speyer-Haus, 60596 Frankfurt am Main, GermanyUrsula Dietrich, Georg-Speyer-Haus, 60596 Frankfurt am Mai...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5643834</comments>
            <pubDate>Fri, 27 Jan 2012 17:53:02 +0100</pubDate>
            <guid isPermaLink="false">5643834</guid>        </item>
        <item>
            <title>A zinc transporter protects from ischemia–reperfusion injury</title>
            <link>http://www.medworm.com/index.php?rid=5635406&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Frl631407053n4457%2F</link>
            <description>Content Type Journal ArticleCategory Clinical ImplicationsPages 1-3DOI 10.1007/s00109-012-0862-7Authors
		Friedrich C. Luft, Experimental and Clinical Research Center, Max-Delbrück Center and Charité Medical Faculty, Lindenbergerweg 80, 13125 Berlin, Germany
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635406</comments>
            <pubDate>Tue, 24 Jan 2012 12:27:18 +0100</pubDate>
            <guid isPermaLink="false">5635406</guid>        </item>
        <item>
            <title>Evolutionary medicine and chronic inflammatory state—known and new concepts in pathophysiology</title>
            <link>http://www.medworm.com/index.php?rid=5635408&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq7513432662408g0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;During the last 10&amp;nbsp;years, a series of exciting observations has led to a new theory of pathophysiology using insights from
 evolutionary biology and neuroendocrine immunology to understand the sequelae of chronic inflammatory disease. According to
 this theory, disease sequelae can be explained based on redirection of energy-rich fuels from storage organs to the activated
 immune system. These disease sequelae are highly diverse and include the following: sickness behavior, anorexia, malnutrition,
 muscle wasting–cachexia, cachectic obesity, insulin resistance with hyperinsulinemia, dyslipidemia, increase of adipose tissue
 near inflamed tissue, alterations of steroid hormone axes, elevated sympathetic tone and local sympathetic nerve fiber loss,
 decreased paras...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635408</comments>
            <pubDate>Tue, 24 Jan 2012 06:54:52 +0100</pubDate>
            <guid isPermaLink="false">5635408</guid>        </item>
        <item>
            <title>Developmental regulation of inflammatory cytokine-mediated Stat3 signaling: the missing link between intrauterine growth restriction and pulmonary dysfunction?</title>
            <link>http://www.medworm.com/index.php?rid=5635407&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq87p862712v18600%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Intrauterine growth restriction (IUGR) is a risk factor for impairment of lung function in adolescence and adulthood. Inflammatory
 and proliferative processes linking IUGR and perturbed extracellular matrix (ECM) as an underlying mechanism have not been
 addressed so far. Therefore, in this study, we aimed to investigate the developmental regulation of inflammatory and profibrotic
 processes in the lung subsequent to IUGR. IUGR was induced in rats by isocaloric protein restriction during gestation. Lung
 function was assessed with direct plethysmography at postnatal day (P) 28 and P70. Lungs were obtained at P1, P42, and P70
 for assessment of mRNA, protein expression, immunohistochemistry, and gelatinolytic activity. Both respiratory system resistance
 and compliance ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5635407</comments>
            <pubDate>Tue, 24 Jan 2012 06:54:52 +0100</pubDate>
            <guid isPermaLink="false">5635407</guid>        </item>
        <item>
            <title>High expression of GCLC is associated with malignant melanoma of low oxidative phenotype and predicts a better prognosis</title>
            <link>http://www.medworm.com/index.php?rid=5617011&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6255566312611151%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Reactive oxygen species (ROS) are strongly implicated in melanoma development, and treatment with antioxidants has shown efficacy
 in suppressing malignant transition and progression. Here, we investigated the significance of the glutamate-l-cysteine ligase catalytic subunit (GCLC) expression, a key regulator of glutathione synthesis, for malignant melanoma. A
 large set of melanoma cell lines (n = 36) was analyzed, and higher GCLC levels were associated with lower presence of intracellular ROS and interestingly also
 lower rates of cell proliferation. Moreover, treatment with the antioxidant N-acetylcysteine efficiently reduced the growth speed of several investigated malignant cells. In addition GCLC expression
 was significantly linked to a prominent set of cellu...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5617011</comments>
            <pubDate>Tue, 17 Jan 2012 07:09:03 +0100</pubDate>
            <guid isPermaLink="false">5617011</guid>        </item>
        <item>
            <title>Angiotensin converting enzyme 2 abrogates bleomycin-induced lung injury</title>
            <link>http://www.medworm.com/index.php?rid=5603989&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F02715hq237m7u728%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Despite substantial progress, mortality and morbidity of the acute respiratory distress syndrome (ARDS), a severe form of
 acute lung injury (ALI), remain unacceptably high. There is no effective treatment for ARDS/ALI. The renin–angiotensin system
 (RAS) through Angiotensin-converting enzyme (ACE)-generated Angiotensin II contributes to lung injury. ACE2, a recently discovered
 ACE homologue, acts as a negative regulator of the RAS and counterbalances the function of ACE. We hypothesized that ACE2
 prevents Bleomycin (BLM)-induced lung injury. Fourteen to 16-week-old ACE2 knockout mice—male (ACE2−/y) and female (ACE2−/−)—and age-matched wild-type (WT) male mice received intratracheal BLM (1.5U/kg). Male ACE2−/y BLM injured mice exhibited poorer exercise c...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5603989</comments>
            <pubDate>Fri, 13 Jan 2012 16:50:02 +0100</pubDate>
            <guid isPermaLink="false">5603989</guid>        </item>
        <item>
            <title>Non-hypoxic stabilization of HIF-Iα during coordinated interaction between Akt and angiopoietin-1 enhances endothelial commitment of bone marrow stem cells</title>
            <link>http://www.medworm.com/index.php?rid=5593011&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F224l5134gq57176t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;We previously reported that mesenchymal stem cells (MSC) co-expressing Akt and angiopoietin-1 (Ang-1) preserved infarcted
 heart function via angiomyogenesis. The present study determined the mechanism of co-overexpression of Akt and Ang-1 in promoting
 endothelial commitment of MSC. The cells were transduced with vectors encoding for Akt (AktMSC), Ang-1 (Ang-1MSC), and both Akt and Ang-1 (AAMSC) using Empty vector transduced MSC (EmpMSC) as control. Molecular studies indicated a coordinated interaction between Akt and Ang-1 in AAMSC and led to non-hypoxic stabilization of hypoxia inducible factor-1α (HIF-Iα) which accentuated under 4-h anoxia. We also
 observed HIF-Iα dependent induction of hemeoxygenase-1, endothelial specific markers and VEGF in AAMSC. Vascular co...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5593011</comments>
            <pubDate>Wed, 11 Jan 2012 17:54:17 +0100</pubDate>
            <guid isPermaLink="false">5593011</guid>        </item>
        <item>
            <title>Inhibitors of hypoxia-inducible factor 1 block breast cancer metastatic niche formation and lung metastasis</title>
            <link>http://www.medworm.com/index.php?rid=5593012&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu4rv372086052357%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Intratumoral hypoxia, a frequent finding in metastatic cancer, results in the activation of hypoxia-inducible factors (HIFs).
 HIFs are implicated in many steps of breast cancer metastasis, including metastatic niche formation through increased expression
 of lysyl oxidase (LOX) and lysyl oxidase-like (LOXL) proteins, enzymes that remodel collagen at the metastatic site and recruit
 bone marrow-derived cells (BMDCs) to the metastatic niche. We investigated the effect of two chemically and mechanistically
 distinct HIF inhibitors, digoxin and acriflavine, on breast cancer metastatic niche formation. Both drugs blocked the hypoxia-induced
 expression of LOX and LOXL proteins, collagen cross-linking, CD11b+ BMDC recruitment, and lung metastasis in an orthotopic breast canc...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5593012</comments>
            <pubDate>Mon, 09 Jan 2012 19:37:55 +0100</pubDate>
            <guid isPermaLink="false">5593012</guid>        </item>
        <item>
            <title>Retraction Note to: Direct renin inhibition: clinical pharmacology</title>
            <link>http://www.medworm.com/index.php?rid=5593013&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb385u4m1666257w1%2F</link>
            <description>Content Type Journal ArticleCategory Retraction NotePages 1-1DOI 10.1007/s00109-011-0850-3Authors
		Michel Azizi, Faculté de Médecine, Université Paris Descartes; Assistance Publique Hôpitaux de Paris, Hôpital Européen Georges Pompidou; INSERM, Clinical Investigation Center 9201, Paris, France
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5593013</comments>
            <pubDate>Mon, 09 Jan 2012 19:37:54 +0100</pubDate>
            <guid isPermaLink="false">5593013</guid>        </item>
        <item>
            <title>A new, powerful player in lipoprotein metabolism: brown adipose tissue</title>
            <link>http://www.medworm.com/index.php?rid=5593016&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9357j6484742k316%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Important causes for modern epidemics such as obesity, diabetes, and cardiovascular disease are over- and malnutrition. Dietary
 as well as endogenous lipids are transported through the bloodstream in lipoproteins, and disturbances in lipoprotein metabolism
 are associated with atherosclerosis, heart disease, and diabetes. Recent findings reveal biological principles—how lipoproteins,
 in particular triglyceride-rich lipoproteins, are metabolized and what factors regulate their processing. The fate of triglycerides
 delivered by lipoproteins is quite simple: either they can be stored or they can be utilized for combustion or biosynthetic
 pathways. In the healthy state, fatty acids derived from triglycerides can be burned in the heart, muscle, and other organs
 for ac...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5593016</comments>
            <pubDate>Mon, 09 Jan 2012 19:37:52 +0100</pubDate>
            <guid isPermaLink="false">5593016</guid>        </item>
        <item>
            <title>Chemopreventive effect of the non-psychotropic phytocannabinoid cannabidiol on experimental colon cancer</title>
            <link>http://www.medworm.com/index.php?rid=5593015&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F26r1060044t401ux%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Colon cancer affects millions of individuals in Western countries. Cannabidiol, a safe and non-psychotropic ingredient of
 Cannabis sativa, exerts pharmacological actions (antioxidant and intestinal antinflammatory) and mechanisms (inhibition of endocannabinoid
 enzymatic degradation) potentially beneficial for colon carcinogenesis. Thus, we investigated its possible chemopreventive
 effect in the model of colon cancer induced by azoxymethane (AOM) in mice. AOM treatment was associated with aberrant crypt
 foci (ACF, preneoplastic lesions), polyps, and tumour formation, up-regulation of phospho-Akt, iNOS and COX-2 and down-regulation
 of caspase-3. Cannabidiol-reduced ACF, polyps and tumours and counteracted AOM-induced phospho-Akt and caspase-3 changes.
 In colorectal ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5593015</comments>
            <pubDate>Mon, 09 Jan 2012 19:37:52 +0100</pubDate>
            <guid isPermaLink="false">5593015</guid>        </item>
        <item>
            <title>IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis</title>
            <link>http://www.medworm.com/index.php?rid=5593014&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa243m68352w34mp1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple Sclerosis (MS) and Rheumatoid Arthritis (RA) are amongst the most common autoimmune diseases in the northern hemisphere.
 There is mounting evidence that in both afflictions, not only environmental and genetic factors influence disease, but cellular
 components such as autoreactive T cells also contribute to pathology. Animal models are key in the study and subsequent therapeutic
 development for human autoimmune diseases. As patient material is often difficult to obtain and in some cases—as in MS, where
 the central nervous system (CNS) is concerned—even not accessible, animal models provide a multifaceted tool to explore disease-underlying
 mechanisms. The pro-inflammatory T cell cytokine IL-17 has recently moved to center stage due to its crucial role in...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5593014</comments>
            <pubDate>Mon, 09 Jan 2012 19:37:52 +0100</pubDate>
            <guid isPermaLink="false">5593014</guid>        </item>
        <item>
            <title>LINE-1 hypomethylation in familial and sporadic cancer</title>
            <link>http://www.medworm.com/index.php?rid=5593017&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv06p47750386710v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Increased and decreased methylation at specific sequences (hypermethylation and hypomethylation, respectively) is characteristic
 of tumor DNA compared to normal DNA and promotes carcinogenesis in multiple ways including genomic instability. Long interspersed
 element (LINE), an abundant class of retrotransposons, provides a surrogate marker for global hypomethylation. We developed
 methylation-specific multiplex ligation-dependent probe amplification assays to study LINE-1 methylation in cases of colorectal,
 gastric, and endometrial cancer (N = 276), stratified by patient category [sporadic; Lynch syndrome (LS); familial colorectal cancer type X (FCCX)] and microsatellite
 instability status. Within each patient group, LINE-1 showed lower methylation in tumor DNA ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5593017</comments>
            <pubDate>Sat, 07 Jan 2012 16:55:24 +0100</pubDate>
            <guid isPermaLink="false">5593017</guid>        </item>
        <item>
            <title>Anti-inflammatory mechanisms and therapeutic opportunities in myocardial infarct healing</title>
            <link>http://www.medworm.com/index.php?rid=5576668&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc25m4730r0621m81%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The wound healing response after myocardial infarction (MI) involves a cascade of molecular and cellular events that lead
 to a replacement of the necrotic area with a collagen-rich scar. Clearance of necrotic debris by neutrophils, monocytes, and
 macrophages is a critical component of infarct healing; however, tight control and timely repression of this inflammatory
 response is important to prevent excessive tissue degradation leading to infarct expansion and heart failure. Genetic ablation
 or blockade of anti-inflammatory pathways tends to be detrimental after MI, whereas genetic ablation of pro-inflammatory pathways
 tends to be beneficial. Accordingly, therapies enhancing endogenous anti-inflammatory pathways or blocking endogenous pro-inflammatory
 pathways have...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576668</comments>
            <pubDate>Fri, 06 Jan 2012 16:47:48 +0100</pubDate>
            <guid isPermaLink="false">5576668</guid>        </item>
        <item>
            <title>Gastrin inhibits a novel, pathological colon cancer signaling pathway involving EGR1, AE2, and P-ERK</title>
            <link>http://www.medworm.com/index.php?rid=5576669&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu1681l060l381535%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Human anion exchanger 2 (AE2) is a plasma membrane protein that regulates intracellular pH and cell volume. AE2 contributes
 to transepithelial transport of chloride and bicarbonate in normal colon and other epithelial tissues. We now report that
 AE2 overexpression in colon cancer cells is correlated with expression of the nuclear proliferation marker, Ki67. Survival
 analysis of 24 patients with colon cancer in early stage or 33 patients with tubular adenocarcinoma demonstrated that expression
 of AE2 is correlated with poor prognosis. Cellular and molecular experiments indicated that AE2 expression promoted proliferation
 of colon cancer cells. In addition, we found that transcription factor EGR1 underlies AE2 upregulation and the AE2 sequester
 p16INK4a (P16) in the...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576669</comments>
            <pubDate>Fri, 06 Jan 2012 16:47:46 +0100</pubDate>
            <guid isPermaLink="false">5576669</guid>        </item>
        <item>
            <title>RhoB is associated with the anti-angiogenic effects of celiac patient transglutaminase 2-targeted autoantibodies</title>
            <link>http://www.medworm.com/index.php?rid=5576670&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx67j4p153p7345ml%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Celiac patient-derived anti-transglutaminase 2 (TG2) antibodies disturb several steps in angiogenesis, but the detailed molecular
 basis is not known. Therefore, we here analyzed by microarray technology the expression of a set of genes related to angiogenesis
 and endothelial cell biology in order to identify factors that could explain our previous data related to vascular biology
 in the context of celiac disease. To this end, in vitro models using human umbilical vein endothelial cells (HUVECs) or in
 vivo models of angiogenesis were used. A total of 116 genes were analyzed after treatment with celiac patient autoantibodies
 against TG2. Compared to treatment with control IgA celiac patient, total IgA induced a consistent expression change of 10
 genes, the up-regula...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5576670</comments>
            <pubDate>Thu, 05 Jan 2012 17:07:55 +0100</pubDate>
            <guid isPermaLink="false">5576670</guid>        </item>
        <item>
            <title>The mitogen-activated protein kinase (MAPK) cascade controls phosphatase and tensin homolog (PTEN) expression through multiple mechanisms</title>
            <link>http://www.medworm.com/index.php?rid=5568839&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff76536q67887w530%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The mitogen-activated protein kinase (MAPK) and PI3K pathways are regulated by extensive crosstalk, occurring at different
 levels. In tumors, transactivation of the alternate pathway is a frequent “escape” mechanism, suggesting that combined inhibition
 of both pathways may achieve synergistic antitumor activity. Here we show that, in the M14 melanoma model, simultaneous inhibition
 of both MEK and mammalian target of rapamycin (mTOR) achieves synergistic effects at suboptimal concentrations, but becomes
 frankly antagonistic in the presence of relatively high concentrations of MEK inhibitors. This observation led to the identification
 of a novel crosstalk mechanism, by which either pharmacologic or genetic inhibition of constitutive MEK signaling restores
 phosph...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568839</comments>
            <pubDate>Wed, 04 Jan 2012 06:58:43 +0100</pubDate>
            <guid isPermaLink="false">5568839</guid>        </item>
        <item>
            <title>Sox9/Sox6 and Sp1 are involved in the insulin-like growth factor-I-mediated upregulation of human type II collagen gene expression in articular chondrocytes</title>
            <link>http://www.medworm.com/index.php?rid=5568840&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx222730122p82135%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Type II collagen is a marker of articular cartilage encoded by the COL2A1 gene. The nature of the trans factors involved in the upregulation of this gene by insulin-like growth factor-I (IGF-I) remains unclear. We found that
 IGF-I increased type II collagen synthesis by a transcriptional control mechanism involving a 715-bp region within the COL2A1 first-intron specific enhancer. The overproduction of L-Sox5/Sox6/Sox9 and Sp1 and decoy experiments targeting these factors
 demonstrated their action in concert in IGF-I trans-activation. These results were supported by the data obtained in knockdown experiments in which siRNA against Sox9/Sox6 and
 Sp1 prevented the IGF-I-induced increase in collagen II production. Indeed, each of these trans-activators increased the expr...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568840</comments>
            <pubDate>Wed, 04 Jan 2012 06:58:42 +0100</pubDate>
            <guid isPermaLink="false">5568840</guid>        </item>
        <item>
            <title>Novel phosphatidylinositol 3-kinase inhibitor NVP-BKM120 induces apoptosis in myeloma cells and shows synergistic anti-myeloma activity with dexamethasone</title>
            <link>http://www.medworm.com/index.php?rid=5568841&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9146ln0114560217%2F</link>
            <description>This study aimed to evaluate the therapeutic efficacy of BKM120 in multiple myeloma (MM). BKM120 induces
 cell growth inhibition and apoptosis in both MM cell lines and freshly isolated primary MM cells. However, BKM120 only shows
 limited cytotoxicity toward normal lymphocytes. The presence of MM bone marrow stromal cells, insulin-like growth factor,
 or interleukin-6 does not affect BKM120-induced tumor cell apoptosis. More importantly, BKM120 treatment significantly inhibits
 tumor growth in vivo and prolongs the survival of myeloma-bearing mice. In addition, BKM120 shows synergistic cytotoxicity
 with dexamethasone in dexamethasone-sensitive MM cells. Low doses of BKM120 and dexamethasone, each of which alone has limited
 cytotoxicity, induce significant cell apoptosis in MM.1S and ARP...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5568841</comments>
            <pubDate>Fri, 30 Dec 2011 07:09:18 +0100</pubDate>
            <guid isPermaLink="false">5568841</guid>        </item>
        <item>
            <title>Antimyeloma activity of the sesquiterpene lactone cnicin: impact on Pim-2 kinase as a novel therapeutic target</title>
            <link>http://www.medworm.com/index.php?rid=5556785&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F3392237728176173%2F</link>
            <description>In this study, we investigate the cytotoxic effect of the natural
 substance cnicin in multiple myeloma. Cnicin treatment reveals potent antiproliferative effects and induces cell death in
 cell lines and primary myeloma cells even in the presence of survival cytokines and the tumor microenvironment. Other cell
 lines of hematopoietic origin also succumb to cell death whereas stromal cells and endothelial cells are unaffected. We show
 that activation of caspases, accumulation of reactive oxygen species and downregulation of nuclear factor kappa-light-chain-enhancer
 of activated B cell contribute to the cytotoxic effects of cnicin. Microarray analysis reveals downregulation of Pim-2, a
 serine/threonine kinase. We provide evidence that Pim-2 constitutes a new survival kinase for myeloma c...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5556785</comments>
            <pubDate>Wed, 28 Dec 2011 16:45:02 +0100</pubDate>
            <guid isPermaLink="false">5556785</guid>        </item>
        <item>
            <title>Distinct regulation of nNOS and iNOS by CB2 receptor in remote delayed neurodegeneration</title>
            <link>http://www.medworm.com/index.php?rid=5542207&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F246vq9l51r834726%2F</link>
            <description>In this study, we found that in the same model, the CB2 agonist JWH-015 enhances neuronal nitric oxide synthase (nNOS) expression in axotomized neurons and that CB2-mediated neuroprotection is abrogated by pharmacological inhibition of nNOS. JWH-015 prevented the axotomy-induced upregulation
 of inducible NOS (iNOS) in astrocytes but had no effect on endothelial NOS (eNOS). In addition, we observed that JWH-015 significantly
 reduces hemicerebellectomy-induced neuroinflammatory responses and oxidative/nitrative stress. With regard to the signaling
 pathways of CB2/nNOS-mediated neuroprotection, we noted nNOS-dependent modulation of the expression of anti-oxidative (Hsp70) and anti-apoptotic
 (Bcl-2) proteins. These findings shed light on the interactions between the endocannabinoid and nit...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5542207</comments>
            <pubDate>Fri, 23 Dec 2011 16:55:13 +0100</pubDate>
            <guid isPermaLink="false">5542207</guid>        </item>
        <item>
            <title>ZnT-1 protects HL-1 cells from simulated ischemia–reperfusion through activation of Ras–ERK signaling</title>
            <link>http://www.medworm.com/index.php?rid=5542208&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu04n188171546342%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Activation of ERK signaling may promote cardioprotection from ischemia–reperfusion (I/R) injury. ZnT-1, a protein that confers
 resistance from zinc toxicity, was found to interact with Raf-1 kinase through its C-terminal domain, leading to downstream
 activation of ERK. In the present study, we evaluated the effects of ZnT-1 in cultured murine cardiomyocytes (HL-1 cells)
 that were exposed to simulated-I/R. Cellular injury was evaluated by lactate dehydrogenase (LDH) release and by staining for
 pro-apoptotic caspase activation. Overexpression of ZnT-1 markedly reduced LDH release and caspase activation following I/R.
 Knockdown of endogenous ZnT-1 augmented the I/R-induced release of LDH and increased caspase activation following I/R. Phospho-ERK
 levels were signif...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5542208</comments>
            <pubDate>Thu, 22 Dec 2011 16:37:47 +0100</pubDate>
            <guid isPermaLink="false">5542208</guid>        </item>
        <item>
            <title>Regenerative potential of glycosaminoglycans for skin and bone</title>
            <link>http://www.medworm.com/index.php?rid=5542209&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy6306074p7tkq434%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;To meet the growing need for tissue replacement materials for our aging population, the development of new adaptive biomaterials
 is essential. The tissues with the highest demand for implant materials are skin and bone. These tissues share various similarities,
 including signaling pathways and extracellular matrix composition. Glycosaminoglycans such as hyaluronan and chondroitin sulfate
 are the major organic extracellular matrix components. They modulate the attraction of skin and bone precursor cells and their
 subsequent differentiation and gene expression and regulate the action of proteins essential to bone and skin regeneration.
 The precise action of glycosaminoglycans varies according to their structural composition mainly in respect to the degree
 of sulfati...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5542209</comments>
            <pubDate>Tue, 20 Dec 2011 16:46:57 +0100</pubDate>
            <guid isPermaLink="false">5542209</guid>        </item>
        <item>
            <title>Sequential targeting of CFTR by BAC vectors generates a novel pig model of cystic fibrosis</title>
            <link>http://www.medworm.com/index.php?rid=5512423&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fp4026g2256867725%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cystic fibrosis (CF) is the most common lethal inherited disease in Caucasians and is caused by mutations in the CFTR gene. The disease is incurable and medical treatment is limited to the amelioration of symptoms or secondary complications.
 A comprehensive understanding of the disease mechanisms and the development of novel treatment options require appropriate
 animal models. Existing CF mouse models fail to reflect important aspects of human CF. We thus generated a CF pig model by
 inactivating the CFTR gene in primary porcine cells by sequential targeting using modified bacterial artificial chromosome vectors. These cells
 were then used to generate homozygous CFTR mutant piglets by somatic cell nuclear transfer. The homozygous CFTR mutants lack CFTR protein expres...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5512423</comments>
            <pubDate>Wed, 14 Dec 2011 16:41:42 +0100</pubDate>
            <guid isPermaLink="false">5512423</guid>        </item>
        <item>
            <title>CCAAT enhancer-binding proteins have long boney fingers</title>
            <link>http://www.medworm.com/index.php?rid=5501083&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F256238u338v6k5t7%2F</link>
            <description>Content Type Journal ArticleCategory Clinical ImplicationsPages 1-3DOI 10.1007/s00109-011-0838-zAuthors
		Friedrich C. Luft, Experimental and Clinical Research Center, Charité Medical Faculty and Max-Delbrück Center for Molecular Medicine, Lindenbergerweg 80, 13125 Berlin, Germany
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5501083</comments>
            <pubDate>Fri, 09 Dec 2011 17:09:36 +0100</pubDate>
            <guid isPermaLink="false">5501083</guid>        </item>
        <item>
            <title>Circulating microRNAs: novel biomarkers for cardiovascular diseases</title>
            <link>http://www.medworm.com/index.php?rid=5492614&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fkvn7803g32451632%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;MicroRNAs (miRNAs) are a novel class of small, non-coding, single-stranded RNAs that negatively regulate gene expression via
 translational inhibition or mRNA degradation followed by protein synthesis repression. Many miRNAs are expressed in a tissue-
 and/or cell-specific manner and their expression patterns are reflective of underlying patho-physiologic processes. miRNAs
 can be detected in serum or in plasma in a remarkably stable form, making them attractive biomarkers for human diseases. This
 review describes the progress of identifying circulating miRNAs as novel biomarkers for diverse cardiovascular diseases, including
 acute myocardial infarction, heart failure, coronary artery disease, diabetes, stroke, essential hypertension, and acute pulmonary
 embolism. In...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5492614</comments>
            <pubDate>Wed, 07 Dec 2011 10:48:17 +0100</pubDate>
            <guid isPermaLink="false">5492614</guid>        </item>
        <item>
            <title>Aberrant epigenetic regulation of bromodomain Brd4 in human colon cancer</title>
            <link>http://www.medworm.com/index.php?rid=5454058&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg521t404343333l4%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The bromodomain protein BRD4 is involved in cell proliferation and cell cycle progression, primarily through its role in acetylated
 chromatin-dependent regulation of transcription at targeted loci. Here, we show that BRD4 is frequently downregulated by aberrant
 promoter hypermethylation in human colon cancer cell lines and primary tumors. Ectopic re-expression of BRD4 in these colon
 cancer cell lines markedly reduced in vivo tumor growth, suggesting a role of BRD4 in human colon cancer.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-9DOI 10.1007/s00109-011-0837-0Authors
		R. M. Rodriguez, Cancer Epigenetics Laboratory, Instituto Universitario de Oncología del Principado de Asturias (IUOPA), HUCA, Universidad de Oviedo, Oviedo, SpainC. Huidobro, Ca...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5454058</comments>
            <pubDate>Sat, 26 Nov 2011 16:48:01 +0100</pubDate>
            <guid isPermaLink="false">5454058</guid>        </item>
        <item>
            <title>Differentiation of multiple types of pancreatico-biliary tumors by molecular analysis of clinical specimens</title>
            <link>http://www.medworm.com/index.php?rid=5454059&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv737r14420u21251%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Timely and accurate diagnosis of pancreatic ductal adenocarcinoma (PDAC) is critical in order to provide adequate treatment
 to patients. However, the clinical signs and symptoms of PDAC are shared by several types of malignant or benign tumors which
 may be difficult to differentiate from PDAC with conventional diagnostic procedures. Among others, these include ampullary
 cancers, solid pseudopapillary tumors, and adenocarcinomas of the distant bile duct, as well as inflammatory masses developing
 in chronic pancreatitis. Here, we report an approach to accurately differentiate between these different types of pancreatic
 masses based on molecular analysis of biopsy material. A total of 156 bulk tissue and fine needle aspiration biopsy samples
 were analyzed using a ded...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5454059</comments>
            <pubDate>Fri, 25 Nov 2011 17:59:55 +0100</pubDate>
            <guid isPermaLink="false">5454059</guid>        </item>
        <item>
            <title>Erbin inhibits TGF-β1-induced EMT in renal tubular epithelial cells through an ERK-dependent pathway</title>
            <link>http://www.medworm.com/index.php?rid=5454060&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg23311234p6m3017%2F</link>
            <description>In this study we demonstrated
 that the expression of Erbin was upregulated in the tubular epithelia of 5/6-nephrectomized rats. We also showed here that
 TGF-β1 upregulated Erbin expression in NRK52E cells during their EMT phenotype acquisition. Importantly, elevated expression
 of Erbin inhibited ERK signaling and partial reversed EMT stimulated by TGF-β1. In the mean time, reducing Erbin expression
 enhanced ERK phosphorylation, promoted the E-cadherin suppression, and induced α-SMA expression and fibronection secretion
 in response to TGF-β1, which could be rescued if cells were treated with the inhibitor of MEK1/2 U0126. However, in the absence
 of TGF-β1, Erbin failed to affect ERK activation and EMT process. These results suggest that Erbin is a negative feedback
 molecule indu...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5454060</comments>
            <pubDate>Thu, 24 Nov 2011 17:49:57 +0100</pubDate>
            <guid isPermaLink="false">5454060</guid>        </item>
        <item>
            <title>Homeobox gene Distal-Less 3 is a regulator of villous cytotrophoblast differentiation and its expression is increased in human idiopathic foetal growth restriction</title>
            <link>http://www.medworm.com/index.php?rid=5454061&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F870811vh395140u4%2F</link>
            <description>In this study, we have investigated the level of DLX3 expression in idiopathic FGR-affected placentae and determined its functional role in villous trophoblast differentiation.
 FGR-affected placentae (n = 25) were collected based on well-defined clinical criteria and matched for gestation with control uncomplicated pregnancies
 (n = 25). Real-time polymerase chain reaction and immunoblotting showed increased DLX3 mRNA and protein expression in FGR-affected placentae compared with gestation-matched controls. Qualitative immunohistochemistry
 revealed DLX3 localisation in the syncytiotrophoblast, cytotrophoblasts and endothelial cells surrounding the foetal capillaries
 in both FGR-affected and control placentae. Down-regulation of DLX3 in primary villous trophoblast cells and a tro...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5454061</comments>
            <pubDate>Wed, 23 Nov 2011 17:42:23 +0100</pubDate>
            <guid isPermaLink="false">5454061</guid>        </item>
        <item>
            <title>Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivity</title>
            <link>http://www.medworm.com/index.php?rid=5447627&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F15356451q3214019%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Rapamycin, a specific inhibitor for mTOR complex 1, is an FDA-approved immunosuppressant for organ transplant. Recent developments
 have raised the prospect of using rapamycin to treat cancer or diabetes and to delay aging. It is therefore important to assess
 how rapamycin treatment affects glucose homeostasis. Here, we show that the same rapamycin treatment reported to extend mouse
 life span significantly impaired glucose homeostasis of aged mice. Moreover, rapamycin treatment of lean C57B/L6 mice reduced
 glucose-stimulated insulin secretion in vivo and ex vivo as well as the insulin content and beta cell mass of pancreatic islets.
 Confounding the diminished capacity for insulin release, rapamycin decreased insulin sensitivity. The multitude of rapamycin
 effects t...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5447627</comments>
            <pubDate>Mon, 21 Nov 2011 18:04:34 +0100</pubDate>
            <guid isPermaLink="false">5447627</guid>        </item>
        <item>
            <title>Leukocyte integrin activation and deactivation: novel mechanisms of balancing inflammation</title>
            <link>http://www.medworm.com/index.php?rid=5437246&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm82q02j118800690%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Leukocyte recruitment into tissue forms the basis of immune surveillance and direct immune defense. It proceeds in a cascade-like
 fashion. The first contact of leukocytes with the endothelium is mediated by selectins and their counter receptors, followed
 by rolling and integrin-mediated arrest. While rolling, neutrophils collect different inflammatory signals which can activate
 several signaling pathways leading to leukocyte adhesion to the endothelium and transmigration through the blood vessel wall
 into the inflamed tissue. Whereas inflammatory reactions are beneficial and necessary for host defense, they need to be balanced
 and controlled to prevent harmful consequences and tissue destruction. In this article, we discuss the different signaling
 pathways that en...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5437246</comments>
            <pubDate>Fri, 18 Nov 2011 17:32:44 +0100</pubDate>
            <guid isPermaLink="false">5437246</guid>        </item>
        <item>
            <title>Salivary transcriptomic biomarkers for detection of ovarian cancer: for serous papillary adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5437247&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcw2002228032r722%2F</link>
            <description>In this study, we spearheaded noninvasive detection of ovarian cancer by salivary
 transcriptomic biomarkers, and evaluated the clinical utilities of discovered biomarkers using a clinical case–control study.
 To find salivary mRNA biomarkers, salivary transcriptomes in 11 ovarian cancer patients and 11 matched controls were profiled
 by Affymetrix HG-U133-Plus-2.0 array. The biomarker candidates selected from the microarray results were then subjected to
 clinical validation by RT-qPCR using an independent sample cohort including 21 ovarian cancer patients and 35 healthy controls.
 Seven downregulated mRNA biomarkers were validated. The logistic regression model revealed the combination of five validated
 biomarkers (AGPAT1, B2M, BASP2, IER3, and IL1B) can significantly discriminate ova...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5437247</comments>
            <pubDate>Fri, 18 Nov 2011 06:58:29 +0100</pubDate>
            <guid isPermaLink="false">5437247</guid>        </item>
        <item>
            <title>Comparative kinome analysis to identify putative colon tumor biomarkers</title>
            <link>http://www.medworm.com/index.php?rid=5437248&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbm437541727735th%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Kinase domains are the type of protein domain most commonly found in genes associated with tumorigenesis. Because of this,
 the human kinome (the protein kinase component of the genome) represents a promising source of cancer biomarkers and potential
 targets for novel anti-cancer therapies. Alterations in the human colon kinome during the progression from normal colon (NC)
 through adenoma (AD) to adenocarcinoma (AC) were investigated using integrated transcriptomic and proteomic datasets. Two
 hundred thirty kinase genes and 42 kinase proteins showed differential expression patterns (fold change ≥ 1.5) in at least
 one tissue pair-wise comparison (AD vs. NC, AC vs. NC, and/or AC vs. AD). Kinases that exhibited similar trends in expression
 at both the mRNA and p...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5437248</comments>
            <pubDate>Fri, 18 Nov 2011 06:58:27 +0100</pubDate>
            <guid isPermaLink="false">5437248</guid>        </item>
        <item>
            <title>Intermittent hypoxia activates temporally coordinated transcriptional programs in visceral adipose tissue</title>
            <link>http://www.medworm.com/index.php?rid=5428033&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft78m1l3878n26503%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Obstructive sleep apnea (OSA) is a prevalent disorder characterized by intermittent hypoxia (IH) during sleep. OSA is strongly
 associated with obesity and dysregulation of metabolism—yet the molecular pathways linking the effects of IH on adipocyte
 biology remain unknown. We hypothesized that exposure to IH would activate distinct, time-dependent transcriptional programs
 in visceral adipose tissue of mice. We exposed 36 mice to IH or normoxia for up to 13&amp;nbsp;days. We transcriptionally profiled
 visceral fat tissue harvested from the animals and performed functional enrichment and network analysis on differentially
 expressed genes. We identified over 3,000 genes with significant expression patterns during the time course of IH exposure.
 The most enriched pathway...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5428033</comments>
            <pubDate>Tue, 15 Nov 2011 16:48:42 +0100</pubDate>
            <guid isPermaLink="false">5428033</guid>        </item>
        <item>
            <title>Suppression of antigen-specific CD4+ T cell activation by SRA/CD204 through reducing the immunostimulatory capability of antigen-presenting cell</title>
            <link>http://www.medworm.com/index.php?rid=5417605&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa476865677757373%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pattern recognition scavenger receptor SRA/CD204, primarily expressed on specialized antigen-presenting cells (APCs), including
 dendritic cells (DCs) and macrophages, has been implicated in multiple physiological and pathological processes, including
 atherosclerosis, Alzheimer’s disease, endotoxic shock, host defense, and cancer development. SRA/CD204 was also recently shown
 to function as an attenuator of vaccine response and antitumor immunity. Here, we, for the first time, report that SRA/CD204
 knockout (SRA−/−) mice developed a more robust CD4+ T cell response than wild-type mice after ovalbumin immunization. Splenic DCs from the immunized SRA−/− mice were much more efficient than those from WT mice in stimulating naïve OT-II cells, indicating that th...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5417605</comments>
            <pubDate>Mon, 14 Nov 2011 16:51:23 +0100</pubDate>
            <guid isPermaLink="false">5417605</guid>        </item>
        <item>
            <title>Rapamycin inhibits osteoclast formation in giant cell tumor of bone through the C/EBPβ - MafB axis</title>
            <link>http://www.medworm.com/index.php?rid=5404732&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj127480253w80763%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Giant cell tumor (GCT) of bone is a benign type of tumor, but the presence of hyperactive multinucleated giant osteoclasts
 cause local osteolytic lesions, increasing morbidity in patients. To specifically target hyperactive multinucleated giant
 osteoclasts in GCTs, one would envisage the usage of osteoclast inhibitors or genetic modulation of osteoclastogenesis. Recently,
 we have found that the translationally regulated balance between the transcription factor C/EBPβ long (LAP) and short (LIP)
 protein isoforms regulates osteoclast differentiation. Here, we report that GCTs express high levels of the LIP C/EBPβ isoform,
 which in mice cause giant osteoclast formation. In mice, inhibition of mTOR activity by rapamycin decreased osteoclast differentiation
 by shiftin...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5404732</comments>
            <pubDate>Wed, 09 Nov 2011 17:51:56 +0100</pubDate>
            <guid isPermaLink="false">5404732</guid>        </item>
        <item>
            <title>Induction of primitive pigment cell differentiation by visible light (helium–neon laser): a photoacceptor-specific response not replicable by UVB irradiation</title>
            <link>http://www.medworm.com/index.php?rid=5404733&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F1630328p25000200%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Solar lights encompass ultraviolet (UV), visible, and infrared spectrum. Most previous studies focused on the harmful UV effects,
 and the biologic effects of lights at other spectrums remained unclear. Recently, lights at visible region have been used
 for regenerative purposes. Using the process of vitiligo repigmentation as a research model, we focused on elucidating the
 pro-differentiation effects induced by visible light. We first showed that helium–neon (He–Ne) laser (632.8&amp;nbsp;nm) irradiation
 stimulated differentiation of primitive pigment cells, an effect not replicable by UVB treatment even at high and damaging
 doses. In addition, significant increases of mitochondrial DNA copy number and the regulatory genes for mitochondrial biogenesis
 were induced b...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5404733</comments>
            <pubDate>Tue, 08 Nov 2011 19:13:00 +0100</pubDate>
            <guid isPermaLink="false">5404733</guid>        </item>
        <item>
            <title>A novel hybrid promoter responsive to pathophysiological and pharmacological regulation</title>
            <link>http://www.medworm.com/index.php?rid=5404734&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0t30x286n5k758n0%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The aim of this study was to construct a promoter containing DNA motifs for an endogenous transcription factor associated
 with inflammation along with motifs for pharmacological regulation factors. We demonstrate in transfected cells that expression
 of a gene of interest is induced by hypoxic conditions or through pharmacological induction, and also show pharmacological
 repression. In vivo studies utilised electroporation of plasmid to mouse paws, a delivery method shown to be effective by
 bioluminescence imaging. For gene therapy, the promoter was used to drive expression of IL-1Ra in a paw inflammation model
 with therapeutic effect observed which was further enhanced when the promoter was additionally induced with a pharmacological
 activator. One of the most imp...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5404734</comments>
            <pubDate>Tue, 08 Nov 2011 19:12:58 +0100</pubDate>
            <guid isPermaLink="false">5404734</guid>        </item>
        <item>
            <title>Intermedin and the unfolded protein response</title>
            <link>http://www.medworm.com/index.php?rid=5396797&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk5435g017744820q%2F</link>
            <description>Content Type Journal ArticleCategory Clinical ImplicationsPages 1-3DOI 10.1007/s00109-011-0827-2Authors
		Friedrich C. Luft, Experimental and Clinical Research Center, Charité Medical Faculty and Max-Delbrück Center for Molecular Medicine, Berlin, Germany
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5396797</comments>
            <pubDate>Thu, 03 Nov 2011 16:53:17 +0100</pubDate>
            <guid isPermaLink="false">5396797</guid>        </item>
        <item>
            <title>SIRT1 is required for long-term growth of human mesenchymal stem cells</title>
            <link>http://www.medworm.com/index.php?rid=5375295&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4r872755602504px%2F</link>
            <description>In this study, we found that NAD-dependent protein deacetylase SIRT1 is differentially expressed
 in both human bone marrow-derived MSCs (B-MSCs) and adipose tissue-derived MSCs after increasing passages of cell culture.
 Using lentiviral shRNA we demonstrated that selective knockdown of SIRT1 in human MSCs at early passage slows down cell growth
 and accelerates cellular senescence. Conversely, overexpression of SIRT1 delays senescence in B-MSCs that have undergone prolonged
 in vitro culturing and the cells do not lose adipogenic and osteogenic potential. In addition, we found that the delayed accumulation
 of the protein p16 is involved in the effect of SIRT1. However, resveratrol, which has been used as an activator of SIRT1
 deacetylase activity, only transiently promotes proliferatio...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5375295</comments>
            <pubDate>Sat, 29 Oct 2011 05:43:39 +0100</pubDate>
            <guid isPermaLink="false">5375295</guid>        </item>
        <item>
            <title>Adenosine A2A receptor activation stimulates collagen production in sclerodermic dermal fibroblasts either directly and through a cross-talk with the cannabinoid system</title>
            <link>http://www.medworm.com/index.php?rid=5375296&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F63r43220511pw769%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Systemic sclerosis (SSc) is a connective tissue disease characterised by exaggerated collagen deposition in the skin and visceral
 organs. Adenosine A2A receptor stimulation (A2Ar) promotes dermal fibrosis, while the cannabinoid system modulates fibrogenesis
 in vitro and in animal models of SSc. Moreover, evidence in central nervous system suggests that A2A and cannabinoid (CB1)
 receptors may physically and functionally interact. On this basis, we investigated A2Ar expression and function in modulating
 collagen biosynthesis from SSc dermal fibroblasts and analysed the cross-talk with cannabinoid receptors. In sclerodermic
 cells, A2Ar expression (RT-PCR, Western blotting) was evaluated together with the effects of A2A agonists and/or antagonists
 on collagen biosynth...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5375296</comments>
            <pubDate>Fri, 28 Oct 2011 06:04:40 +0100</pubDate>
            <guid isPermaLink="false">5375296</guid>        </item>
        <item>
            <title>An intronic MYLK variant associated with inflammatory lung disease regulates promoter activity of the smooth muscle myosin light chain kinase isoform</title>
            <link>http://www.medworm.com/index.php?rid=5343502&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F21710q48315123w3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Intronic single-nucleotide polymorphisms (SNPs) are commonly associated with complex diseases but exhibit unknown biologic
 functionality. Myosin light-chain kinase (MLCK), a central cytoskeletal regulator encoded by MYLK, plays a key pathophysiological role in complex diseases including acute lung injury (ALI) and asthma. We studied the potential
 regulatory roles of two intronic MYLK SNPs (rs936170 and rs820336) previously associated with ALI and asthma. Due to their genomic location at the junction encoding
 the non-muscle and smooth muscle MLCK (smMLCK) isoforms, we first identified the transcription start site (TSS) of the smMLCK
 isoform, and isolated a 2,954-bp DNA fragment upstream of the smMLCK TSS. Serial 5′ deletion of the fragment revealed a proximal
 prom...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5343502</comments>
            <pubDate>Thu, 20 Oct 2011 15:47:40 +0100</pubDate>
            <guid isPermaLink="false">5343502</guid>        </item>
        <item>
            <title>Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2</title>
            <link>http://www.medworm.com/index.php?rid=5343503&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fbk776u24kh41t051%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;RU486 (Mifepristone) has been known as antiprogesterone and antiglucocorticoid agent. RU486 is also used for treatment of
 several cancers, such as breast, ovarian, prostate, and glaucoma. Here, we investigated the effect of RU486 on TRAIL-induced
 apoptosis in human renal carcinoma Caki cells. Low dose of RU486 (30–50&amp;nbsp;μM) alone had no effect on apoptosis, but RU486 markedly
 sensitized Caki cells to TRAIL-induced apoptosis. We found that up-regulation of death receptor 5 (DR5; receptor for TRAIL
 ligand), and down-regulation of Bcl-2 and c-FLIP (caspase regulator) contributes to RU-486 induced TRAIL sensitization. Down-regulation
 of DR5 by siRNA also blocked RU486 induced TRAIL sensitization. Furthermore, overexpression of Bcl-1 or c-FLIP(L) inhibited
 the cel...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5343503</comments>
            <pubDate>Wed, 19 Oct 2011 05:54:43 +0100</pubDate>
            <guid isPermaLink="false">5343503</guid>        </item>
        <item>
            <title>Identification of secretory gelsolin as a plasma biomarker associated with distant organ metastasis of colorectal cancer</title>
            <link>http://www.medworm.com/index.php?rid=5330602&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd07451rq1r405j24%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Colorectal cancer (CRC) is one of the most common cancers worldwide. More than half of all CRC patients will develop metastases,
 which represents the major cause of death for CRC patients. CRC metastases confined in other organs are potentially resectable,
 and patients who receive curative resections appear to have better outcomes. Thus, the early detection of metastasis in CRC
 patients could improve their survival rate after curative surgery. Here, we report the use of Cy-dye labeling combined with
 multi-dimensional fractionation and mass spectrometry as a proteomics-based approach for identifying CRC metastasis-associated
 biomarker(s) in plasma samples collected from three CRC patients upon diagnosis of their primary and metastatic tumors. Among
 the eight identi...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5330602</comments>
            <pubDate>Thu, 13 Oct 2011 15:50:45 +0100</pubDate>
            <guid isPermaLink="false">5330602</guid>        </item>
        <item>
            <title>Rv0315, a novel immunostimulatory antigen of Mycobacterium tuberculosis, activates dendritic cells and drives Th1 immune responses</title>
            <link>http://www.medworm.com/index.php?rid=5321507&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F201ul55115486725%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb) is one of the most deadly infectious diseases, with approximately two million people dying of TB annually. An effective
 therapeutic method for activating dendritic cells (DCs) and driving Th1 immune responses would improve host defenses and further
 the development of a TB vaccine. Given the importance of DC maturation in eliciting protective immunity against TB, we investigated
 whether Rv0315, a newly identified Mtb antigen, can prompt DC maturation. We found that Rv0315 functionally activated DCs
 by augmenting the expression of the co-stimulatory molecules CD80 and CD86 as well as MHC class I/II molecules. Moreover,
 it increased DC secretion of the pro-inflammatory cytokines IL-6, IL-1β, and TNF-α. Unl...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5321507</comments>
            <pubDate>Wed, 12 Oct 2011 16:32:29 +0100</pubDate>
            <guid isPermaLink="false">5321507</guid>        </item>
        <item>
            <title>The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications</title>
            <link>http://www.medworm.com/index.php?rid=5281464&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxx684613651t0497%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Immune disorders are linked to the development of type 2 diabetes (T2D) and its complications. The relationship of CD4+CD25hi T regulatory cells (Treg) and pro-inflammatory Th17 and Th1 subsets in T2D patients with metabolic disorders and complications
 need to be determined. The ratios of CD4+CD25hi Treg/Th17 cells and CD4+CD25hi Treg/Th1 cells, but not Th17/Th1 cells, were significantly decreased in T2D patients. The thymic output CD4+Foxp3+Helios+ Tregs were normal but peripheral induced CD4+Foxp3+Helios− Tregs were decreased in T2D patients. The Bcl-2/Bax ratio decreased in CD4+CD25hi Tregs in T2D patients, supporting the increased sensitivity to cell death of these cells in T2D. CD4+CD25hiCD127− Tregs in T2D patients with microvascular complications were signif...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5281464</comments>
            <pubDate>Sat, 01 Oct 2011 05:48:22 +0100</pubDate>
            <guid isPermaLink="false">5281464</guid>        </item>
        <item>
            <title>Differentially expressed genes in human peripheral blood as potential markers for statin response</title>
            <link>http://www.medworm.com/index.php?rid=5257268&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk241720702m15552%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;There is a considerable inter-individual variation in response to statin therapy and one third of patients do not meet their
 treatment goals. We aimed to identify differentially expressed genes that might be involved in the effects of statin treatment
 and to suggest potential markers to guide statin therapy. Forty-six healthy Korean subjects received atorvastatin; their whole-genome
 expression profiles in peripheral blood were analyzed before and after atorvastatin administration in relation with changes
 in lipid profiles. The expression patterns of the differentially expressed genes were also compared with the data of familial
 hypercholesterolemia (FH) patients and controls. Pairwise comparison analyses revealed differentially expressed genes involved
 in diverse ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5257268</comments>
            <pubDate>Fri, 23 Sep 2011 15:51:45 +0100</pubDate>
            <guid isPermaLink="false">5257268</guid>        </item>
        <item>
            <title>S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI Imaging</title>
            <link>http://www.medworm.com/index.php?rid=5257269&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fy0173410468154x6%2F</link>
            <description>In this study, we found 36 mass-to-charge-ratio (m/z) species that specifically distinguished metastatic from non-metastatic tumors, among which m/z 11,608 was identified as thioredoxin, m/z 11,184 as S100-A10, and m/z 10,094 as S100-A6. Furthermore, using IHC on the validation set, we showed that the overexpression of these three proteins
 was highly associated with lymph node metastasis in PTC (p &amp;lt; 0.005). For functional analysis of the metastasis-specific proteins, we performed an Ingenuity Pathway Analysis and discovered
 a strong relationship of all candidates with the TGF-β-dependent EMT pathway. Our results demonstrated the potential application
 of the MALDI-IMS proteomic approach in identifying protein markers of metastasis in PTC. The novel protein markers identified
 in ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5257269</comments>
            <pubDate>Thu, 22 Sep 2011 05:52:49 +0100</pubDate>
            <guid isPermaLink="false">5257269</guid>        </item>
        <item>
            <title>Modulation of anthracycline-induced cytotoxicity by targeting the prenylated proteome in myeloid leukemia cells</title>
            <link>http://www.medworm.com/index.php?rid=5233428&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd464307n41q92707%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Deregulation of Ras/ERK signaling in myeloid leukemias makes this pathway an interesting target for drug development. Myeloid
 leukemia cell lines were screened for idarubicin-induced apoptosis, cell-cycle progression, cell-cycle-dependent MAP kinase
 kinase (MEK-1/2) activation, and Top2 expression. Cell-cycle-dependent activation of MEK/ERK signaling was blocked using farnesyltransferase
 inhibitor (FTI) BMS-214,662 and dual prenyltransferase inhibitor (DPI) L-778,123 to disrupt Ras signaling. Idarubicin caused
 a G2/M cell-cycle arrest characterized by elevated diphosphorylated MEK-1/2 and Top2α expression levels. The FTI/DPIs elicited
 distinct effects on Ras signaling, protein prenylation, cell cycling and apoptosis. Combining these FTI/DPIs with idarubicin
 syner...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5233428</comments>
            <pubDate>Wed, 14 Sep 2011 05:52:38 +0100</pubDate>
            <guid isPermaLink="false">5233428</guid>        </item>
        <item>
            <title>IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment model</title>
            <link>http://www.medworm.com/index.php?rid=5233427&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm410u04772q38553%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;IRX-2, a natural cytokine biological with multiple components, has been used in preclinical and clinical studies to promote
 antitumor activity of T lymphocytes. To define cellular mechanisms responsible for antitumor effects of IRX-2, its ability
 to induce effector T cells (Teff) was examined in a model simulating the tumor microenvironment. An in vitro model containing
 conventional CD4+CD25− cells co-cultured with autologous immature dendritic cells, irradiated tumor cells, and cytokines was used to study differentiation
 and expansion of regulatory T cells (Treg) and Teff in the presence and absence of IRX-2. Phenotype, suppressor function,
 signaling, and cytokine production were serially measured using flow cytometry, Western blots, CFSE-based suppressor assays...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5233427</comments>
            <pubDate>Wed, 14 Sep 2011 05:52:38 +0100</pubDate>
            <guid isPermaLink="false">5233427</guid>        </item>
        <item>
            <title>Role of interleukin 1 beta in esophageal squamous cell carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=5233429&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F602254758232854r%2F</link>
            <description>In conclusion, IL-1 beta is significantly linked to poor prognosis for patients with esophageal
 cancer and may be a promising molecular target for therapeutic intervention for esophageal SCC.
 
 
	Content Type Journal ArticleCategory Original ArticlePages 1-12DOI 10.1007/s00109-011-0809-4Authors
		Miao-Fen Chen, Department of Radiation Oncology, Chang Gung Memorial Hospital at Chia-Yi, Chia-Yi, TaiwanMing-Shian Lu, Department of Thoracic &amp; Cardiovascular Surgery, Chang Gung Memorial Hospital at Chia-Yi, Chia-Yi, TaiwanPing-Tsung Chen, Department of Hematology and Oncology, Chang-Gung Memorial Hospital, Chia-Yi, #6, Chia-Pu Rd, Putz City, Chia-Yi Hsien, TaiwanWen-Cheng Chen, Department of Radiation Oncology, Chang Gung Memorial Hospital at Chia-Yi, Chia-Yi, TaiwanPaul-Yang Lin, Department ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5233429</comments>
            <pubDate>Mon, 12 Sep 2011 15:50:50 +0100</pubDate>
            <guid isPermaLink="false">5233429</guid>        </item>
        <item>
            <title>Inhibition of endoplasmic reticulum stress by intermedin1–53 protects against myocardial injury through a PI3 kinase–Akt signaling pathway</title>
            <link>http://www.medworm.com/index.php?rid=5217682&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fqj525550535t88k3%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Intermedin (IMD) is a novel member of the calcitonin/calcitonin gene-related peptide family. We aimed to explore whether the
 cardioprotective effect of IMD is mediated by inhibiting myocardial endoplasmic reticulum (sarcoplasmic reticulum) stress
 (ERS). In vitro, IMD1–53 (10−9, 10−8, and 10−7&amp;nbsp;mol/l) directly inhibited the upregulation of ERS markers such as glucose-regulated protein 78, CCAAT/enhancer binding protein
 homologous protein, and caspase-12 induced by the ERS inducers tunicamycin (Tm, 10&amp;nbsp;mg/ml) or dithiothreitol (DTT, 2&amp;nbsp;mmol/l)
 in cardiac tissue. IMD1–53 also inhibited Tm- or DTT-induced upregulation of cleaved activating transcription factor 6 and 4. These inhibitory effects
 of IMD1–53 were abolished by the IMD receptor antago...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5217682</comments>
            <pubDate>Sat, 10 Sep 2011 15:48:35 +0100</pubDate>
            <guid isPermaLink="false">5217682</guid>        </item>
        <item>
            <title>Bortezomib represses HIF-1α protein expression and nuclear accumulation by inhibiting both PI3K/Akt/TOR and MAPK pathways in prostate cancer cells</title>
            <link>http://www.medworm.com/index.php?rid=5217683&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff1371662n3011t76%2F</link>
            <description>In this study, we investigated the effect of bortezomib on the expression,
 activity and localization of HIF-1α in LNCaP (AD) and PC3 (AI) PCa cells. First, we show that hypoxic upregulation of HIF-1α
 protein levels and activity involves both the PI3K/Akt/mTOR and p44/42 MAPK pathways. Second, bortezomib inhibits expression
 of HIF-1α protein under both normoxic and hypoxic conditions, represses HIF-1 transcriptional activity and attenuates the
 release of vascular endothelial growth factor. These effects correlate with the ability of bortezomib to cause dephosphorylation
 of phospho-Akt, phospho-p70S6K, and phospho-S6RP, thus inactivating a pathway known to be required for HIF-1α protein expression
 at the translational level. Furthermore, bortezomib also abrogates p44/42 MAPK phosph...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5217683</comments>
            <pubDate>Sat, 10 Sep 2011 06:01:58 +0100</pubDate>
            <guid isPermaLink="false">5217683</guid>        </item>
        <item>
            <title>Blood coagulation factor XII—a neglected player in stroke pathophysiology</title>
            <link>http://www.medworm.com/index.php?rid=5217684&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F63n33306304126v7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ischemic stroke is a devastating disease which, in most cases, is caused by thrombotic occlusion of brain arteries. The molecular
 mechanisms involved in microvascular thrombus formation during focal cerebral ischemia are not well understood. As a consequence,
 the current antithrombotic drugs used to treat acute stroke or prevent stroke recurrence either show limited efficacy or put
 patients at risk for serious bleeding complications. The serine protease blood coagulation factor XII (FXII) initiates the
 intrinsic pathway of coagulation which, together with the extrinsic pathway, culminates in the formation of fibrin. A physiological
 function of FXII in clot formation and hemostasis in vivo has been questioned for more than 50&amp;nbsp;years. This was mainly due
 to the ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5217684</comments>
            <pubDate>Fri, 09 Sep 2011 16:46:38 +0100</pubDate>
            <guid isPermaLink="false">5217684</guid>        </item>
        <item>
            <title>A novel molecular mechanism to explain biotin-unresponsive holocarboxylase synthetase deficiency</title>
            <link>http://www.medworm.com/index.php?rid=5204145&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8h35104w28n35j30%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Biotin (vitamins H and B7) is an important micronutrient as defects in its availability, metabolism or adsorption can cause
 serious illnesses, especially in the young. A key molecule in the biotin cycle is holocarboxylase synthetase (HLCS), which
 attaches biotin onto the biotin-dependent enzymes. Patients with congenital HLCS deficiency are prescribed oral biotin supplements
 that, in most cases, reverse the clinical symptoms. However, some patients respond poorly to biotin therapy and have an extremely
 poor long-term prognosis. Whilst a small number of mutations in the HLCS gene have been implicated, the molecular mechanisms
 that lead to the biotin-unresponsive phenotype are not understood. To improve our understanding of HLCS, limited proteolysis
 was performed to...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5204145</comments>
            <pubDate>Tue, 06 Sep 2011 05:48:26 +0100</pubDate>
            <guid isPermaLink="false">5204145</guid>        </item>
        <item>
            <title>Genetic variants in candidate genes influencing NAFLD progression</title>
            <link>http://www.medworm.com/index.php?rid=5204146&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb135kmhl138671r7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Nonalcoholic fatty liver disease (NAFLD) is a metabolic disorder including simple steatosis and nonalcoholic steatohepatitis
 (NASH). Advanced stages of NASH result ultimately in fibrosis, cirrhosis, and hepatocarcinoma. A diagnosis of NASH entails
 an increased risk of both liver-related and cardiovascular mortality as worsening of the metabolic syndrome. Because of its
 escalation, many investigations have been performed to elucidate the pathophysiologic origins of the disease progression.
 Human epidemiologic studies describing polymorphisms in a number of genes involved in metabolic dysfunctions have contributed
 to clarify the causes leading to the disease evolution. In this review, we attempt to outline critically the most recently
 identified genetic variants in ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5204146</comments>
            <pubDate>Mon, 05 Sep 2011 16:16:42 +0100</pubDate>
            <guid isPermaLink="false">5204146</guid>        </item>
        <item>
            <title>Time for endothelial cell proprotein convertase PC5/6 in cardiovascular medicine?</title>
            <link>http://www.medworm.com/index.php?rid=5194787&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ff7j15256x435m757%2F</link>
            <description>Content Type Journal ArticleCategory Clinical ImplicationsPages 1-3DOI 10.1007/s00109-011-0810-yAuthors
		Jan Fritzsche, Department of Medicine/Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, GermanyPhilipp Stawowy, Department of Medicine/Cardiology, Deutsches Herzzentrum Berlin, Augustenburger Platz 1, 13353 Berlin, Germany
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5194787</comments>
            <pubDate>Fri, 02 Sep 2011 05:50:38 +0100</pubDate>
            <guid isPermaLink="false">5194787</guid>        </item>
        <item>
            <title>Involvement of TNFα-induced TLR4–NF-κB and TLR4–HIF-1α feed-forward loops in the regulation of inflammatory responses in glioma</title>
            <link>http://www.medworm.com/index.php?rid=5194786&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F826433863l851815%2F</link>
            <description>In this study, we observed heightened TLR4 levels in GBM tumor samples as compared to adjacent normal tissue.
 Since the pro-inflammatory cytokine tumor necrosis factor (TNF)α induces NF-κB activation in GBM, and as several common signaling
 mediators are involved in TNFα and TLR4-mediated NF-κB activation, we investigated the role of TLR4 in the regulation of NF-κB
 activation and inflammatory responses in TNFα-treated glioma cells. TNFα elevated TLR4 expression and inhibition of TLR4 signaling
 by either signaling inhibitor, neutralizing antibody, or small interfering RNA (siRNA)-attenuated TNFα-induced NF-κB activation.
 TLR4-mediated NF-κB activation was independent of canonical myeloid differentiation factor 88 signaling but involved toll/IL-1R
 homology domain-containing ad...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5194786</comments>
            <pubDate>Fri, 02 Sep 2011 05:50:38 +0100</pubDate>
            <guid isPermaLink="false">5194786</guid>        </item>
        <item>
            <title>Therapeutic inhibition of fatty acid oxidation in right ventricular hypertrophy: exploiting Randle’s cycle</title>
            <link>http://www.medworm.com/index.php?rid=5173928&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fpj5q71428613536v%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Right ventricular hypertrophy (RVH) and RV failure are major determinants of prognosis in pulmonary hypertension and congenital
 heart disease. In RVH, there is a metabolic shift from glucose oxidation (GO) to glycolysis. Directly increasing GO improves
 RV function, demonstrating the susceptibility of RVH to metabolic intervention. However, the effects of RVH on fatty acid
 oxidation (FAO), the main energy source in adult myocardium, are unknown. We hypothesized that partial inhibitors of FAO (pFOXi)
 would indirectly increase GO and improve RV function by exploiting the reciprocal relationship between FAO and GO (Randle’s
 cycle). RVH was induced in adult Sprague-Dawley rats by pulmonary artery banding (PAB). pFOXi were administered orally to
 prevent (trimetazidine...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5173928</comments>
            <pubDate>Sat, 27 Aug 2011 15:48:07 +0100</pubDate>
            <guid isPermaLink="false">5173928</guid>        </item>
        <item>
            <title>Transcript signature predicts tissue NK cell content and defines renal cell carcinoma subgroups independent of TNM staging</title>
            <link>http://www.medworm.com/index.php?rid=5173929&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fu23033073p645263%2F</link>
            <description>We report that the NK cell percentage within RCC-infiltrating
 lymphocytes, as determined by flow cytometry, allows ccRCC subgrouping in NKhigh/NKlow tissues independent of TNMG classification. Quantitative reverse transcriptase polymerase chain reaction using whole-tissue
 RNA identified four markers (NKp46, perforin, CX3CL1, and CX3CR1) whose transcript levels reproduced the NKhigh/NKlow tissue distinction identified by flow cytometry with high selectivity and specificity. Combined in a multiplex profile and
 analyzed using neural network, the accuracy of predicting the NKhigh/NKlow groups was 87.8%, surpassing that of each single marker. The tissue transcript signature, based on a robust high-throughput
 methodology, is easily amenable to archive material and clinical translation. This ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5173929</comments>
            <pubDate>Thu, 25 Aug 2011 15:48:03 +0100</pubDate>
            <guid isPermaLink="false">5173929</guid>        </item>
        <item>
            <title>Nod2: a key regulator linking microbiota to intestinal mucosal immunity</title>
            <link>http://www.medworm.com/index.php?rid=5155612&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6t805r855522m714%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The human intestine harbors a large number of bacteria that are constantly interacting with the intestinal immune system,
 eliciting non-pathological basal level immune responses. Increasing evidence points to dysbiosis of microbiota in the intestine
 as an underlying factor in inflammatory bowel disease susceptibility. Loss-of-function mutations in NOD2 are among the stronger
 genetic factors linked to ileal Crohn’s disease. Indeed, Nod2 is a key regulator of microbiota in the intestine, as microflora
 in the terminal ileum is dysregulated in Nod2-deficient mice. Nod2 is highly expressed in Paneth cells, which are responsible for the regulation of ileal microflora by
 anti-microbial compounds, and Nod2-deficient ileal intestinal epithelia are unable to kill bacteria ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5155612</comments>
            <pubDate>Mon, 22 Aug 2011 16:06:40 +0100</pubDate>
            <guid isPermaLink="false">5155612</guid>        </item>
        <item>
            <title>HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy</title>
            <link>http://www.medworm.com/index.php?rid=5155613&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0kj72487235141u3%2F</link>
            <description>In this study, we employed the
 FcγRs to target DCs both in vitro and in vivo. We designed a recombinant molecule (HER2-Fc) composed of the immunogenic sequence
 of the human tumor-associated antigen HER2 (aa 364–391) and the Fc domain of a human IgG1. In a mouse model, HER2-Fc cDNA vaccination activated significant T cell-mediated immune responses towards HER2 peptide epitopes
 as detected by IFN-γ ELIspot and induced longer tumor latency as compared to Ctrl-Fc-vaccinated control mice. Human in vitro
 studies indicated that the recombinant HER2-Fc immunogen efficiently targeted human DCs through the FcγRs resulting in protein
 cross-processing and in the activation of autologous HER2-specific CD8+ T cells from breast cancer patients.
 
 
	Content Type Journal ArticleCategory Original...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5155613</comments>
            <pubDate>Tue, 16 Aug 2011 06:08:28 +0100</pubDate>
            <guid isPermaLink="false">5155613</guid>        </item>
        <item>
            <title>MT1-MMP and RECK: opposite and essential roles in hematopoietic stem and progenitor cell retention and migration</title>
            <link>http://www.medworm.com/index.php?rid=5137794&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2m6v4383202vq268%2F</link>
            <description>We report
 that while the metalloproteinase membrane type 1-metalloprotease (MT1-MMP) has an essential role in human HSPC trafficking
 during granulocyte colony-stimulating factor (G-CSF)-induced mobilization, its inhibitor reversion-inducing cysteine-rich
 protein with Kazal motifs (RECK) and the adhesion molecule CD44 are required for HSPC retention to the BM in steady-state
 conditions. The nervous system via Wnt signaling along with HGF/c-Met signaling and the complement cascade play a major role
 in regulating MT1-MMP increased activity, CD44 cleavage, and RECK-reduced expression during G-CSF-induced mobilization. This
 review will elaborate on the opposite roles of MT1-MMP and RECK in HSPC migration and retention and suggest targeting them
 in order to facilitate HSPC mobilization an...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5137794</comments>
            <pubDate>Sat, 13 Aug 2011 06:08:14 +0100</pubDate>
            <guid isPermaLink="false">5137794</guid>        </item>
        <item>
            <title>Regulation of arterial blood pressure by Akt1-dependent vascular relaxation</title>
            <link>http://www.medworm.com/index.php?rid=5137793&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa8487p4732486004%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Endothelial cell-dependent vascular relaxation plays an important role in the regulation of blood pressure. Here, we show
 that stimulation of vascular endothelial cells with platelet-derived growth factor (PDGF) results in vascular relaxation through
 Akt1-dependent activation of endothelial nitric oxide synthase (eNOS) and nitric oxide (NO) production. Stimulation of both
 human umbilical artery endothelial cells and abdominal aortic vessels with PDGF induced NO production. PDGF-dependent production
 of NO was completely abolished by inhibition of phosphatidylinositol 3-kinase with wortmannin (100&amp;nbsp;nM). Stimulation of aortic
 vessels with PDGF resulted in the activation of Akt phosphorylation and eNOS phosphorylation: however, eNOS phosphorylation
 and production ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5137793</comments>
            <pubDate>Sat, 13 Aug 2011 06:08:14 +0100</pubDate>
            <guid isPermaLink="false">5137793</guid>        </item>
        <item>
            <title>Erratum to: T-cell-based vaccination for morphological and functional neuroprotection in a rat model of chronically elevated intraocular pressure</title>
            <link>http://www.medworm.com/index.php?rid=5129932&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F5521351871658515%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00109-011-0789-4Authors
		Sharon Bakalash, Department of Neurobiology, The Weizmann Institute of Science, 76100 Rehovot, IsraelGil Ben-Shlomo, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, IsraelEyal Aloni, Department of Ophthalmology, Kaplan Medical Center, Rehovot, IsraelIftach Shaked, Department of Neurobiology, The Weizmann Institute of Science, 76100 Rehovot, IsraelLarry Wheeler, Department of Biological Sciences, Allergan Pharmaceuticals, Irvine, CA, USARon Ofri, Koret School of Veterinary Medicine, The Hebrew University of Jerusalem, Rehovot, IsraelMichal Schwartz, Department of Neurobiology, The Weizmann Institute of Science, 76100 Rehovot, Israel
	

	
		Journal Journal of Molecular MedicineOnli...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5129932</comments>
            <pubDate>Thu, 11 Aug 2011 06:56:47 +0100</pubDate>
            <guid isPermaLink="false">5129932</guid>        </item>
        <item>
            <title>Molecular mechanisms underlying cardiac antihypertrophic and antifibrotic effects of natriuretic peptides</title>
            <link>http://www.medworm.com/index.php?rid=5124411&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F824n681964u30113%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Natriuretic peptides (NPs) exert well-characterized protective effects on the cardiovascular system, such as vasorelaxation,
 natri- and diuresis, increase of endothelial permeability, and inhibition of renin–angiotensin–aldosterone system. It has
 been reported that they also possess antihypertrophic and antifibrotic properties and contribute actively to cardiac remodeling.
 As a consequence, they are involved in several aspects of cardiovascular diseases. Antihypertrophic and antifibrotic actions
 of NPs appear to be mediated by specific signaling pathways within a more complex cellular network. Elucidation of the molecular
 mechanisms underlying the effects of NPs on cardiac remodeling represents an important research objective in order to gain
 more insights on ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5124411</comments>
            <pubDate>Mon, 08 Aug 2011 19:55:14 +0100</pubDate>
            <guid isPermaLink="false">5124411</guid>        </item>
        <item>
            <title>Lymphocyte α-kinase is a gout-susceptible gene involved in monosodium urate monohydrate-induced inflammatory responses</title>
            <link>http://www.medworm.com/index.php?rid=5117078&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn6lx1l73ttm65211%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The molecular functions and pathophysiologic role of the lymphocyte α-kinase gene (ALPK1) in gout are unknown. We aimed to examine ALPK1 expression in patients with gout and investigate its role in monosodium urate monohydrate (MSU)-induced inflammatory responses.
 Microarray data mining was performed with six datasets containing three clinical gout and three volunteer samples. Real-time
 quantitative polymerase chain reaction (qPCR) assay was used to profile ALPK1 mRNA expression in 62 independent samples. RNA interference for ALPK1 suppression in THP1 cells (human monocytic cell line) was used to scrutinize the functional role of ALPK1 in MSU-mediated inflammatory responses, and ALPK1 expression in MSU-treated THP1 cells was determined by qPCR and Western blot analys...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5117078</comments>
            <pubDate>Sun, 07 Aug 2011 05:52:39 +0100</pubDate>
            <guid isPermaLink="false">5117078</guid>        </item>
        <item>
            <title>ε/ζ systems: their role in resistance, virulence, and their potential for antibiotic development</title>
            <link>http://www.medworm.com/index.php?rid=5117081&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2089360vt7125r41%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cell death in bacteria can be triggered by activation of self-inflicted molecular mechanisms. Pathogenic bacteria often make
 use of suicide mechanisms in which the death of individual cells benefits survival of the population. Important elements for
 programmed cell death in bacteria are proteinaceous toxin–antitoxin systems. While the toxin generally resides dormant in
 the bacterial cytosol in complex with its antitoxin, conditions such as impaired de novo synthesis of the antitoxin or nutritional
 stress lead to antitoxin degradation and toxin activation. A widespread toxin–antitoxin family consists of the ε/ζ systems,
 which are distributed over plasmids and chromosomes of various pathogenic bacteria. In its inactive state, the bacteriotoxic
 ζ toxin protein...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5117081</comments>
            <pubDate>Sat, 06 Aug 2011 05:59:56 +0100</pubDate>
            <guid isPermaLink="false">5117081</guid>        </item>
        <item>
            <title>A novel role of andrographolide, an NF-kappa B inhibitor, on inhibition of platelet activation: the pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP</title>
            <link>http://www.medworm.com/index.php?rid=5117080&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa515804811r61630%2F</link>
            <description>This study demonstrates for the
 first time that andrographolide possesses a novel role of antiplatelet activity, which may involve the activation of the eNOS-NO/cyclic
 GMP pathway, resulting in the inhibition of the PI3 kinase/Akt-p38 MAPK and PLCγ2–PKC cascades, thereby leading to inhibition
 of platelet aggregation.
 
 
	Content Type Journal ArticlePages 1-13DOI 10.1007/s00109-011-0800-0Authors
		Wan-Jung Lu, Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taipei, TaiwanJie-Jen Lee, Department of Surgery, Mackay Memorial Hospital, Taipei, TaiwanDuen-Suey Chou, Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, 250 Wuxing St., Taipei, 11031 TaiwanThanasekaran Jayakumar, Graduate Institute of Medical ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5117080</comments>
            <pubDate>Sat, 06 Aug 2011 05:59:56 +0100</pubDate>
            <guid isPermaLink="false">5117080</guid>        </item>
        <item>
            <title>Braking self-cannibalism in cancer</title>
            <link>http://www.medworm.com/index.php?rid=5117079&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fjp8722203624q6q1%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00109-011-0791-xAuthors
		Friedrich C. Luft, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Lindenbergerweg 80, 13125 Berlin, Germany
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5117079</comments>
            <pubDate>Sat, 06 Aug 2011 05:59:56 +0100</pubDate>
            <guid isPermaLink="false">5117079</guid>        </item>
        <item>
            <title>Chipping away at the surface of the endothelial progenitor cell (EPC) mystery</title>
            <link>http://www.medworm.com/index.php?rid=5117082&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F948131h313215n50%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00109-011-0799-2Authors
		Jalees Rehman, Section of Cardiology, Department of Medicine and Department of Pharmacology, College of Medicine, University of Illinois at Chicago, (M/C 868) 835 S. Wolcott Ave. Rm. E403, Chicago, IL 60612, USA
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5117082</comments>
            <pubDate>Sat, 06 Aug 2011 05:59:52 +0100</pubDate>
            <guid isPermaLink="false">5117082</guid>        </item>
        <item>
            <title>Spinophilin regulates central angiotensin II-mediated effect on blood pressure</title>
            <link>http://www.medworm.com/index.php?rid=5106086&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fd1250n3176l72029%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Central angiotensin II (AngII) plays an important role in the regulation of the sympathetic nervous system. The underlining
 molecular mechanisms are largely unknown. Spinophilin (SPL) is a regulator of G protein-coupled receptor signaling. Deletion
 of SPL induces sympathetically mediated arterial hypertension in mice. We tested the hypothesis that SPL restrains blood pressure
 (BP) by regulating AngII activity. We equipped SPL−/− and SPL+/+ mice with telemetric devices and applied AngII (1.0&amp;nbsp;mg&amp;nbsp;kg−1&amp;nbsp;day−1, minipumps) or the AngII subtype 1 receptor (AT1-R) blocker valsartan (50&amp;nbsp;mg&amp;nbsp;kg−1&amp;nbsp;day−1, gavage). We assessed autonomic nervous system activity through intraperitoneal application of trimethaphan, metoprolol,
 and atropine. W...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5106086</comments>
            <pubDate>Fri, 05 Aug 2011 05:52:57 +0100</pubDate>
            <guid isPermaLink="false">5106086</guid>        </item>
        <item>
            <title>Emerging roles of molecular chaperones and co-chaperones in selective autophagy: focus on BAG proteins</title>
            <link>http://www.medworm.com/index.php?rid=5106085&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmr065k9083w37663%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Macroautophagy is a catabolic process by which the cell degrades cytoplasmic components through the lysosomal machinery. While
 initially acknowledged as a rather unspecific bulk degradation process, growing lines of evidence indicate the selectivity
 of macroautophagy pathways in the removal of misfolded or aggregated proteins. How such substrates are recognized and specifically
 targeted to the macroautophagy machinery has become a hotspot of investigation, and recent evidence suggests that here molecular
 chaperones and co-chaperones play a central role. One emerging pathway is mediated by the co-chaperone protein Bcl-2-associated
 athanogene 3 (BAG 3) which seems to utilize the specificity of molecular chaperones (heat-shock proteins) towards non-native
 proteins as...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5106085</comments>
            <pubDate>Fri, 05 Aug 2011 05:52:57 +0100</pubDate>
            <guid isPermaLink="false">5106085</guid>        </item>
        <item>
            <title>Increased hepatic apoptosis in high-fat diet-induced NASH in rats may be associated with downregulation of hepatic stimulator substance</title>
            <link>http://www.medworm.com/index.php?rid=5106087&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa35753u256212584%2F</link>
            <description>In conclusion, these data imply that cell apoptosis contributes to the pathogenesis of NASH, during which HSS expression is
 downregulated. Increasing HSS expression in hepatocytes may forestall cell apoptosis as result of fatty acid insult.
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s00109-011-0790-yAuthors
		Ying Jiang, Department of Cell Biology and Municipal Laboratory for Liver Protection and Regulation of Liver Regeneration, Capital Medical University, 10 You An Men Wai Xi Tou Tiao, 100069 Beijing, ChinaMiaoyun Zhao, Department of Cell Biology and Municipal Laboratory for Liver Protection and Regulation of Liver Regeneration, Capital Medical University, 10 You An Men Wai Xi Tou Tiao, 100069 Beijing, ChinaWei An, Department of Cell Biology and Municipal Laboratory for Live...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5106087</comments>
            <pubDate>Thu, 04 Aug 2011 15:23:28 +0100</pubDate>
            <guid isPermaLink="false">5106087</guid>        </item>
        <item>
            <title>Pyruvate dehydrogenase inhibition by the inflammatory cytokine TNFα contributes to the pathogenesis of pulmonary arterial hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5102757&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fg53j445141r3m749%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pulmonary arterial hypertension (PAH) is a vascular remodeling disease characterized by enhanced proliferation and suppressed
 apoptosis of pulmonary artery smooth muscle cells (PASMC). This apoptosis resistance is characterized by PASMC mitochondrial
 hyperpolarization [in part, due to decreased pyruvate dehydrogenase (PDH) activity], decreased mitochondrial reactive oxygen
 species (mROS), downregulation of Kv1.5, increased [Ca++]i, and activation of the transcription factor nuclear factor of activated T cells (NFAT). Inflammatory cells are present within
 and around the remodeled arteries and patients with PAH have elevated levels of inflammatory cytokines, including tumor necrosis
 factor-α (TNFα). We hypothesized that the inflammatory cytokine TNFα inhibits PASM...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5102757</comments>
            <pubDate>Tue, 02 Aug 2011 05:54:18 +0100</pubDate>
            <guid isPermaLink="false">5102757</guid>        </item>
        <item>
            <title>Suppression of CFTR premature termination codons and rescue of CFTR protein and function by the synthetic aminoglycoside NB54</title>
            <link>http://www.medworm.com/index.php?rid=5061493&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fq47t3298814520g1%2F</link>
            <description>We examined
 whether NB54 administration rescued CFTR protein and function in clinically relevant CF models. In a fluorescence-based halide
 efflux assay, NB54 partially restored halide efflux in a CF bronchial epithelial cell line (CFTR genotype W1282X/F508del), but not in a CF epithelial cell line lacking a PTC (F508del/F508del). In polarized airway epithelial cells expressing either a CFTR-W1282X or -G542X cDNA, treatment with NB54 increased stimulated short-circuit current (I
 SC) with greater efficiency than gentamicin. NB54 and gentamicin induced comparable increases in forskolin-stimulated I
 SC in primary airway epithelial cells derived from a G542X/F508del CF donor. Systemic administration of NB54 to Cftr−/− mice expressing a human CFTR-G542X transgene restored 15–17% of the...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5061493</comments>
            <pubDate>Thu, 21 Jul 2011 17:56:42 +0100</pubDate>
            <guid isPermaLink="false">5061493</guid>        </item>
        <item>
            <title>Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo</title>
            <link>http://www.medworm.com/index.php?rid=5061494&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ftt37351261001555%2F</link>
            <description>We report the analysis of CPI-613, the first member of a large set of analogs of lipoic acid (lipoate) we have investigated
 as potential anticancer agents. CPI-613 strongly disrupts mitochondrial metabolism, with selectivity for tumor cells in culture.
 This mitochondrial disruption includes activation of the well-characterized, lipoate-responsive regulatory phosphorylation
 of the E1α pyruvate dehydrogenase (PDH) subunit. This phosphorylation inactivates flux of glycolysis-derived carbon through
 this enzyme complex and implicates the PDH regulatory kinases (PDKs) as a possible drug target. Supporting this hypothesis,
 RNAi knockdown of the PDK protein levels substantially attenuates CPI-613 cancer cell killing. In both cell culture and in
 vivo tumor environments, the observed strong m...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5061494</comments>
            <pubDate>Tue, 19 Jul 2011 05:49:55 +0100</pubDate>
            <guid isPermaLink="false">5061494</guid>        </item>
        <item>
            <title>From oncoproteins/tumor suppressors to microRNAs, the newest therapeutic targets for pulmonary arterial hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5048281&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F96742130l5648042%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Pulmonary arterial hypertension (PAH) is a disease of the pulmonary vasculature characterized by constricted and remodeled
 pulmonary arteries. This phenomenon is associated with enhanced pulmonary artery smooth muscle cells proliferation and suppressed
 apoptosis, metabolism shift, inflammation, and several other features that are considered as hallmarks of cancer. Since oncogenes,
 tumor suppressors, and miRNAs are the major regulators of signaling in the cancer phenotype, we studied if the same type of
 regulation is operative in PAH. From the discovery of BMPR2 mutation in familial forms of PAH, oncogenic pathways activation
 like MAPK were identified. Recently, the Src/STAT3/Pim1 axis was also described as playing a critical role in PAH pathogenesis.
 Moreover, thr...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5048281</comments>
            <pubDate>Thu, 14 Jul 2011 16:50:34 +0100</pubDate>
            <guid isPermaLink="false">5048281</guid>        </item>
        <item>
            <title>The miRNA pathway in neurological and skeletal muscle disease: implications for pathogenesis and therapy</title>
            <link>http://www.medworm.com/index.php?rid=5035409&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx5g1532585852302%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;RNA interference (RNAi) represents a powerful post-transcriptional gene silencing network which fine-tunes gene expression
 in all eukaryotic cells. The endogenous triggers of RNAi, microRNAs (miRNAs), are proposed to regulate expression of up to
 a third of all protein-coding genes, and have been shown to have critical roles in developmental processes including in the
 central nervous system and skeletal muscle. Further, many have been reported to display differential expression in various
 disease states. Here we describe present understanding of the biogenesis and function of miRNAs, review current knowledge
 of miRNA abnormalities in both human neurological and skeletal muscle disease and discuss their potential as novel disease
 biomarkers. Finally, we highlight th...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5035409</comments>
            <pubDate>Wed, 13 Jul 2011 06:01:19 +0100</pubDate>
            <guid isPermaLink="false">5035409</guid>        </item>
        <item>
            <title>Cellular and molecular choreography of neutrophil recruitment to sites of sterile inflammation</title>
            <link>http://www.medworm.com/index.php?rid=5035410&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fem811q6xp326r853%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Liberation of damage-associated molecular patterns (DAMPs) following tissue injury and necrotic cell death leads to the induction
 of sterile inflammation. A hallmark of acute inflammation is the recruitment of neutrophils to injured tissues. This review
 focuses on the journey of neutrophils to sites of sterile inflammation and the cellular and molecular mechanisms that choreograph
 this complex voyage. We review the pathway of leukocyte recruitment, with emphasis on recent additions to our understanding
 of intravascular neutrophil migration. The contributions of various tissue-resident sentinel cell populations to the detection
 of danger signals (DAMPs) and coordination of neutrophil recruitment and migration are discussed. In addition, we highlight
 recent data on ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5035410</comments>
            <pubDate>Wed, 13 Jul 2011 06:01:18 +0100</pubDate>
            <guid isPermaLink="false">5035410</guid>        </item>
        <item>
            <title>Linking new and old concepts: inflammation meets the Warburg phenomenon in pulmonary arterial hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5017805&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F723502r340740772%2F</link>
            <description>Content Type Journal ArticlePages 1-4DOI 10.1007/s00109-011-0783-xAuthors
		Todd M. Kolb, Division of Pulmonary and Critical Care Medicine and Department of Medicine, Johns Hopkins University School of Medicine, 1830 East Monument Street, 5th Floor, Baltimore, MD 21205, USARachel L. Damico, Division of Pulmonary and Critical Care Medicine and Department of Medicine, Johns Hopkins University School of Medicine, 1830 East Monument Street, 5th Floor, Baltimore, MD 21205, USAPaul M. Hassoun, Division of Pulmonary and Critical Care Medicine and Department of Medicine, Johns Hopkins University School of Medicine, 1830 East Monument Street, 5th Floor, Baltimore, MD 21205, USA
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medi...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5017805</comments>
            <pubDate>Thu, 07 Jul 2011 05:50:12 +0100</pubDate>
            <guid isPermaLink="false">5017805</guid>        </item>
        <item>
            <title>Design and validation of an endothelial progenitor cell capture chip and its application in patients with pulmonary arterial hypertension</title>
            <link>http://www.medworm.com/index.php?rid=5017806&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F640xl76m5913103t%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The number of circulating endothelial progenitor cells (EPCs) inversely correlates with cardiovascular risk and clinical outcome,
 and thus has been proposed as a valuable biomarker for risk assessment, disease progression, and response to therapy. However,
 current strategies for isolation of these rare cells are limited to complex, laborious approaches. The goal of this study
 was the design and validation of a disposable microfluidic platform capable of selectively capturing and enumerating EPCs
 directly from human whole blood in healthy and diseased subjects, eliminating sample preprocessing. We then applied the “EPC
 capture chip” clinically and determined EPC numbers in blood from patients with pulmonary arterial hypertension (PAH). Blood
 was collected in tu...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5017806</comments>
            <pubDate>Thu, 07 Jul 2011 05:50:10 +0100</pubDate>
            <guid isPermaLink="false">5017806</guid>        </item>
        <item>
            <title>Vitamin K supplementation increases vitamin K tissue levels but fails to counteract ectopic calcification in a mouse model for pseudoxanthoma elasticum</title>
            <link>http://www.medworm.com/index.php?rid=4997151&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn45761543xg0h3wx%2F</link>
            <description>In conclusion, dietary MK-7 supplementation increased vitamin K tissue levels in the PXE mouse model but failed
 to counteract ectopic calcification. Hence, we obtained no support for the hypothesis that Abcc6 transports vitamin K and
 that PXE can be cured by increasing tissue levels of vitamin K.
 
 
	Content Type Journal ArticlePages 1-11DOI 10.1007/s00109-011-0782-yAuthors
		Theo G. M. F. Gorgels, Department of Clinical and Molecular Ophthalmogenetics, The Netherlands Institute for Neuroscience (NIN), an Institute of the Royal Netherlands Academy of Arts and Sciences (KNAW), Meibergdreef 47, 1105 BA Amsterdam, The NetherlandsJan H. Waarsing, Department of Orthopaedics, Erasmus Medical Center, Dr. Molewaterplein 50-60, Rotterdam, The NetherlandsMarjolein Herfs, VitaK and Cardiovascular ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4997151</comments>
            <pubDate>Fri, 01 Jul 2011 17:43:16 +0100</pubDate>
            <guid isPermaLink="false">4997151</guid>        </item>
        <item>
            <title>Cancer suicide gene therapy with TK.007: superior killing efficiency and bystander effect</title>
            <link>http://www.medworm.com/index.php?rid=4967578&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F325613801l5466q7%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Suicide gene therapy is a promising concept in oncology. We have recently introduced a novel suicide gene, TK.007, which was
 shown to excel established herpes simplex virus thymidine kinase (HSVtk) variants when used for donor-lymphocyte modification
 in adoptive immunotherapy models. Here, the potential of TK.007 in killing cancer cells was studied. Initially, we transduced
 tumour cell lines derived from different neoplasias (glioblastoma, melanoma, lung cancer, colon cancer) with lentiviral LeGO
 vectors encoding TK.007 or the splice-corrected (sc)HSVtk together with an eGFP/Neo-marker. Based on direct in vitro comparison,
 we found that TK.007 facilitates more efficient tumour cell killing at significantly lower ganciclovir doses in all tumour
 cell lines tested. A...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4967578</comments>
            <pubDate>Wed, 22 Jun 2011 15:57:48 +0100</pubDate>
            <guid isPermaLink="false">4967578</guid>        </item>
        <item>
            <title>Nickel allergies: paying the Toll for innate immunity</title>
            <link>http://www.medworm.com/index.php?rid=4967577&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb7528422l3705883%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Allergic contact hypersensitivity responses to the transition metal nickel (Ni2+) affect millions of people worldwide despite extensive legislatory efforts to ban the use of Ni2+ in products coming into direct contact with the skin. Like other contact allergens, Ni2+ triggers a T lymphocyte-driven delayed-type hypersensitivity reaction that is characterized by leukocyte infiltration at
 sites of allergen exposure. The last years have revealed that besides a hapten-specific T cell response, Ni2+ can also directly trigger an innate immune response in resident skin cells that is necessary for mounting an allergic hypersensitivity
 reaction to Ni2+. Recently, the receptor for the bacterial membrane component lipopolysaccharide, Toll-like receptor 4, has been identified
 as ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4967577</comments>
            <pubDate>Wed, 22 Jun 2011 15:57:48 +0100</pubDate>
            <guid isPermaLink="false">4967577</guid>        </item>
        <item>
            <title>Correction of endothelial dysfunction after selective homocysteine lowering gene therapy reduces arterial thrombogenicity but has no effect on atherogenesis</title>
            <link>http://www.medworm.com/index.php?rid=4959255&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj07330rh05540562%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hyperhomocysteinemia is an independent risk factor for ischemic cardiovascular diseases, but its causal role in atherothrombosis
 remains controversial. Proatherogenic and/or prothrombotic effects may underlie the potential causal relation between hyperhomocysteinemia
 and cardiovascular events. Here, the effects of selective lowering of plasma homocysteine, plasma cholesterol, or both on
 endothelial function and on atherogenesis in male hyperlipidemic and hyperhomocysteinemic C57BL/6 low-density lipoprotein receptor (LDLr)−/−/cystathionine-β-synthase (CBS)+/−-deficient mice were investigated. Second, we evaluated whether selective homocysteine lowering has anti-thrombotic effects
 in a model of arterial thrombosis. A hyperhomocysteinemic and atherogenic diet wa...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4959255</comments>
            <pubDate>Sat, 18 Jun 2011 05:41:44 +0100</pubDate>
            <guid isPermaLink="false">4959255</guid>        </item>
        <item>
            <title>Inactivation of endothelial proprotein convertase 5/6 decreases collagen deposition in the cardiovascular system: role of fibroblast autophagy</title>
            <link>http://www.medworm.com/index.php?rid=4951341&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc122w833k74k324x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Proprotein convertase (PC) 5/6 belongs to a family of secretory proteases involved in proprotein proteolysis. Several studies
 suggest a role for PC5/6 in cardiovascular disease. Because lethality at birth of mice lacking PC5/6 precluded elucidation
 of its function in the adult, we generated mice in which the gene of PC5/6 (pcsk5) is specifically inactivated in endothelial cells (ecKO), which are viable and do not exhibit overt abnormalities. In order
 to uncover the function of PC5/6 in the cardiovascular system, the effect of ecKO was studied in aging mice. In 16 to 18-month-old
 ecKO mice, the left ventricle (LV) mass, media cross-sectional area of aorta and coronary arteries, and media-to-lumen ratio
 of mesenteric arteries were decreased. The LV presented decrease...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4951341</comments>
            <pubDate>Fri, 17 Jun 2011 11:59:58 +0100</pubDate>
            <guid isPermaLink="false">4951341</guid>        </item>
        <item>
            <title>Autophagy suppression promotes apoptotic cell death in response to inhibition of the PI3K—mTOR pathway in pancreatic adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=4951342&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj43j7g54g644058x%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Targeting of pathways downstream of RAS represents a promising therapeutic strategy for pancreatic cancer, the fourth leading
 cause of cancer-related death in the USA, since activation of the Raf-MEK-ERK and PI3K-AKT pathways is found frequently in
 this disease and is associated with poor prognosis. Taking advantage of a panel of human PDAC cell lines and specific inhibitors
 of PI3K and/or mTOR, we systematically address the question whether dual-targeted inhibition of the PI3K and mTOR pathways
 offers advantages over single-targeted inhibition of PI3K in PDAC. We observe greater overall susceptibility of cell lines
 to dual inhibition compared to targeting PI3K alone. However, we find that dual inhibition of PI3K and mTOR induces autophagy
 to a greater extent than...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4951342</comments>
            <pubDate>Thu, 16 Jun 2011 05:51:43 +0100</pubDate>
            <guid isPermaLink="false">4951342</guid>        </item>
        <item>
            <title>MiR-106a inhibits glioma cell growth by targeting E2F1 independent of p53 status</title>
            <link>http://www.medworm.com/index.php?rid=4932242&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F87085252527n3004%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;MicroRNAs are single-stranded small non-coding RNA molecules which regulate mammalian cell growth, differentiation, and apoptosis
 by altering the expression of other genes and play a role in tumor genesis and progression. MiR-106a is upregulated in several
 types of malignancies and provides a pro-tumorigenic effect. However, its role in glioma is largely unknown. Our findings
 demonstrate that the low expression of miR-106a in human glioma specimens is significantly correlated with high levels of
 E2F1 protein and high-grade glioma. Here, we present the first evidence that miR-106a provides a tumor-suppressive effect
 via suppressing proliferation of and inducing apoptosis in human glioma cells. We further show that E2F1 is a direct functional
 target of miR-106a, sug...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4932242</comments>
            <pubDate>Thu, 09 Jun 2011 05:44:29 +0100</pubDate>
            <guid isPermaLink="false">4932242</guid>        </item>
        <item>
            <title>Nrf2-dependent gene expression is affected by the proatherogenic apoE4 genotype—studies in targeted gene replacement mice</title>
            <link>http://www.medworm.com/index.php?rid=4901271&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F2050471735351237%2F</link>
            <description>In this study, we show that Nrf2-dependent gene expression is affected by the apoE genotype.
 ApoE4 vs. apoE3 mice exhibited lower hepatic Nrf2 nuclear protein levels. Furthermore, mRNA and protein levels of Nrf2 target
 genes including glutathione-S-transferase, heme oxygenase-1 and NAD(P)H dehydrogenase, quinone 1 were significantly lower
 in apoE4 as compared to apoE3 mice. Lower hepatic mRNA levels of phase II enzymes, as observed in apoE4 vs. apoE3 mice, were
 accompanied by higher mRNA levels of phase I enzymes including Cyp26a1 and Cyp3a16. Furthermore, miRNA-144, miRNA-125b, and
 miRNA-29a involved in Nrf2 signaling, inflammation, and regulation of phase I enzyme gene expression were affected by the
 apoE genotype. We provide first evidence that Nrf2 is differentially regulated in ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4901271</comments>
            <pubDate>Fri, 27 May 2011 18:13:03 +0100</pubDate>
            <guid isPermaLink="false">4901271</guid>        </item>
        <item>
            <title>Identification of a coronary stem cell in the human heart</title>
            <link>http://www.medworm.com/index.php?rid=4901272&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw715053427672416%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Human ischemic cardiomyopathy is characterized by de novo cardiomyogenesis, which is limited to the surviving portion of the
 ventricle, and by organ hypertrophy that develops as a chronic response to ischemic injury. Although myocyte hypertrophy and
 myocyte regeneration restore the original myocardial mass, the coronary vasculature remains defective and the extent and regulation
 of myocardial perfusion are severely impaired. Recently, vascular stem cells (VSCs) have been identified in the coronary circulation.
 VSCs express c-kit and the vascular endothelial growth factor receptor-2, KDR. These cells are self-renewing, clonogenic,
 and multipotent in vitro and in vivo. In animal models of critical coronary artery stenosis, VSCs form large conductive coronary
 arterie...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4901272</comments>
            <pubDate>Mon, 23 May 2011 16:49:41 +0100</pubDate>
            <guid isPermaLink="false">4901272</guid>        </item>
        <item>
            <title>Connecting the renin–angiotensin–aldosterone system with sudden death</title>
            <link>http://www.medworm.com/index.php?rid=4901273&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Flh36h70q02402754%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00109-011-0772-0Authors
		Friedrich C. Luft, Experimental and Clinical Research Center, a joint cooperation between the Charité Medical Faculty and the Max-Delbrück Center for Molecular Medicine, Berlin, Lindenbergerweg 80, 13125 Berlin, Germany
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4901273</comments>
            <pubDate>Mon, 23 May 2011 16:49:37 +0100</pubDate>
            <guid isPermaLink="false">4901273</guid>        </item>
        <item>
            <title>Gene expression differences between stroke-associated and asymptomatic carotid plaques</title>
            <link>http://www.medworm.com/index.php?rid=4901274&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4708783863621731%2F</link>
            <description>This study presents a comprehensive transcriptional
 analysis of stroke-associated CPs and demonstrates a significant transcriptome difference between stroke-associated and asymptomatic
 CPs. Follow-up studies on the identified genes are needed to define whether they could be used as biomarkers of symptomatic
 CPs or have a role in plaque destabilization.
 
 
	Content Type Journal ArticlePages 1-12DOI 10.1007/s00109-011-0773-zAuthors
		Jani Saksi, Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, P.O. Box700, Haartmaninkatu 8, FI-00290 Helsinki, FinlandPetra Ijäs, Research Programs Unit, Molecular Neurology, Biomedicum Helsinki, University of Helsinki, P.O. Box700, Haartmaninkatu 8, FI-00290 Helsinki, FinlandKrista Nuotio, Research Programs Unit, Mo...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4901274</comments>
            <pubDate>Mon, 23 May 2011 16:49:36 +0100</pubDate>
            <guid isPermaLink="false">4901274</guid>        </item>
        <item>
            <title>Non-cell-autonomous tumor suppression: oncogene-provoked apoptosis promotes tumor cell senescence via stromal crosstalk</title>
            <link>http://www.medworm.com/index.php?rid=4852261&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl8464v8q77u6lw51%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Activated oncogenes evoke cellular fail-safe programs such as apoptosis, senescence, or autophagy to protect the organism
 from the expansion of damaged and potentially harmful cells. Non-cell-autonomous interactions between tumor cells and nonmalignant
 bystander cells add to cell-autonomous modes of tumor suppression during tumor development and progression. In particular,
 the role of stroma or host immune cells converting tumor-generated signals into a response that feeds back to the tumor cell
 population has been experimentally underappreciated. Using the Eμ-myc transgenic mouse lymphoma model, we elucidated how constitutive Myc signaling indirectly promotes cellular senescence via
 cytokines that were released by nonmalignant cells in response to oncogene-evoked...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4852261</comments>
            <pubDate>Wed, 18 May 2011 18:18:26 +0100</pubDate>
            <guid isPermaLink="false">4852261</guid>        </item>
        <item>
            <title>Novel ARF/p53-independent senescence pathways in cancer repression</title>
            <link>http://www.medworm.com/index.php?rid=4852262&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F4024v042n22755k8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cellular senescence, which can be induced by various stimuli, is a stress response that manifests as irreversible cell cycle
 arrest. Recent studies have revealed that cellular senescence can serve as a critical barrier for cancer development. Induction
 of cellular senescence by oncogenic insults, such as Ras overexpression or by inactivation of PTEN tumor suppressor, triggers
 an ARF/p53-dependent tumor-suppressive effect which can significantly restrict cancer progression. Given the important role
 of the ARF/p53 pathway in cellular senescence and tumor suppression, drugs that stabilize p53 expression have been developed
 and tested in clinical trials. However, a major hurdle for p53 targeting in cancer treatment arises from the frequent deficiency
 or mutation of AR...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4852262</comments>
            <pubDate>Wed, 18 May 2011 18:18:25 +0100</pubDate>
            <guid isPermaLink="false">4852262</guid>        </item>
        <item>
            <title>Arsenic trioxide induces autophagy and apoptosis in human glioma cells in vitro and in vivo through downregulation of survivin</title>
            <link>http://www.medworm.com/index.php?rid=4852263&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Ft748u123764tm304%2F</link>
            <description>This study suggests that ATO treatment or survivin inhibition could be a novel therapeutic strategy in malignant
 gliomas.
 
 
	Content Type Journal ArticlePages 1-15DOI 10.1007/s00109-011-0763-1Authors
		Hui-Wen Chiu, Department of Environmental and Occupational Health, National Cheng Kung University Medical College, 138 Sheng-Li Road, Tainan, 704 TaiwanYuan-Soon Ho, School of Medical Laboratory Science and Biotechnology, College of Medical Science and Technology, Taipei Medical University, Taipei, TaiwanYing-Jan Wang, Department of Environmental and Occupational Health, National Cheng Kung University Medical College, 138 Sheng-Li Road, Tainan, 704 Taiwan
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4852263</comments>
            <pubDate>Wed, 18 May 2011 18:18:24 +0100</pubDate>
            <guid isPermaLink="false">4852263</guid>        </item>
        <item>
            <title>Erasing injury-related cortical synaptic potentiation as a new treatment for chronic pain</title>
            <link>http://www.medworm.com/index.php?rid=4839661&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fa18034p037q71h80%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Synaptic plasticity in the spinal cord and the cortex is believed to be important for the amplification of painful information
 in chronic pain conditions. The investigation of molecular mechanism responsible for maintaining injury-related plastic changes,
 such as through the study of long-term potentiation in these structures, provides potential novel targets for designing new
 medicine for chronic pain. Recent studies using integrative neurobiological approaches demonstrate that protein kinase M zeta
 (PKMζ) maintains pain-induced persistent changes in the anterior cingulate cortex (ACC), and inhibiting PKMζ by ζ-pseudosubstrate
 inhibitory peptide produces analgesic effects in animal models of chronic pain. We propose that targeting PKMζ, or its up-
 or downstre...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4839661</comments>
            <pubDate>Mon, 16 May 2011 08:42:24 +0100</pubDate>
            <guid isPermaLink="false">4839661</guid>        </item>
        <item>
            <title>Danger signals activating innate immunity in graft-versus-host disease</title>
            <link>http://www.medworm.com/index.php?rid=4839662&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh260324436p12086%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Extensive cell death with consecutive release of danger signals can cause immune-mediated tissue destruction. The abundance
 of cell death is likely to determine the relevance of the danger signals as physiological mechanisms that counteract immune
 activation may be overruled. Such constellation is conceivable in chemo-/radiotherapy-induced tissue damage, reperfusion injury,
 trauma, and severe infection. Studies on graft-versus-host disease (GvHD) development have to consider the effects of chemo-/radiotherapy-related
 tissue damage leading to the release of exogenous and endogenous danger signals. Our previous work has demonstrated a role
 for adenosine-5′-triphosphate (ATP) as an endogenous danger signal in GvHD. Besides ATP, uric acid or soluble extracellular
 ma...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4839662</comments>
            <pubDate>Sat, 14 May 2011 15:53:37 +0100</pubDate>
            <guid isPermaLink="false">4839662</guid>        </item>
        <item>
            <title>Epitope mapping and structural analysis of the anti-Der p 1 monoclonal antibody: insight into therapeutic potential</title>
            <link>http://www.medworm.com/index.php?rid=4839663&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F6213864p62653044%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Group 1 allergen from Dermatophagoid pteronyssinus (Der p 1) belongs to the papain-like cysteine protease family and is a major cause of allergic rhinitis and asthma. An anti-Der
 p 1 monoclonal antibody, mAb W108, was selected and isolated from Der p-specific IgG2b-producing hybridoma clones. Two-dimensional
 electrophoresis and immunoblotting showed that mAb W108 reacted with four components of Der p extracts with a molecular mass
 of 35&amp;nbsp;kDa and pI values varying from 4 to 6; it also reacted with IgE antibodies in the sera of Der p-sensitive patients. In the competitive
 assay and using azocasein as a substrate, we found that mAb W108 inhibited not only the binding of Der p 1, but also its cysteine
 protease activity in a dose-dependent manner. The two peptide se...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4839663</comments>
            <pubDate>Thu, 12 May 2011 16:38:36 +0100</pubDate>
            <guid isPermaLink="false">4839663</guid>        </item>
        <item>
            <title>Animal models and molecular imaging tools to investigate lymph node metastases</title>
            <link>http://www.medworm.com/index.php?rid=4819652&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F9h23m52811520001%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Lymph node metastasis is a strong predictor of poor outcome in cancer patients. Animal studies of lymph node metastasis are
 constrained by difficulties in the establishment of appropriate animal models, limitations in the noninvasive monitoring of
 lymph node metastasis progression, and challenges in the pathologic confirmation of lymph node metastases. In this comprehensive
 review, we summarize available preclinical animal cancer models for noninvasive imaging and identification of lymph node metastases
 of non-hematogenous cancers. Furthermore, we discuss the strengths and weaknesses of common noninvasive imaging modalities
 used to identify tumor-bearing lymph nodes and provide guidelines for their pathological confirmation.
 
 
	Content Type Journal ArticlePages 1...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4819652</comments>
            <pubDate>Tue, 10 May 2011 06:03:12 +0100</pubDate>
            <guid isPermaLink="false">4819652</guid>        </item>
        <item>
            <title>Development of genetically engineered CD4+ and CD8+ T cells expressing TCRs specific for a M. tuberculosis 38-kDa antigen</title>
            <link>http://www.medworm.com/index.php?rid=4819653&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F821p45831m014n23%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Cell-mediated immunity is critical to the clearance of Mycobacterium tuberculosis due to the primarily intracellular niche of this pathogen. Adoptive transfer of M. tuberculosis-specific effector T cells has been shown to confer immunity to M. tuberculosis-infected recipients resulting in M. tuberculosis clearance. However, it is difficult to generate sufficient numbers of M. tuberculosis antigen-specific T cells in a short time. Recent studies have developed T cell receptor (TCR) gene-modified T cells that
 allow for the rapid generation of large numbers of antigen-specific T cells. Many TCRs that target various tumor and viral
 antigens have now been isolated and shown to have functional activity. Nevertheless, TCRs specific for intracellular bacterial
 antigens (incl...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4819653</comments>
            <pubDate>Tue, 10 May 2011 06:03:11 +0100</pubDate>
            <guid isPermaLink="false">4819653</guid>        </item>
        <item>
            <title>Slouching towards gene therapy for hypercholesterolemia</title>
            <link>http://www.medworm.com/index.php?rid=4819654&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe245x1q8116373n6%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00109-011-0765-zAuthors
		Friedrich C. Luft, Experimental and Clinical Research Center, Charité Medical, Faculty and Max-Delbrück Center for Molecular Medicine, Berlin, Germany
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4819654</comments>
            <pubDate>Mon, 09 May 2011 05:34:57 +0100</pubDate>
            <guid isPermaLink="false">4819654</guid>        </item>
        <item>
            <title>Inhibition of renin-angiotensin system (RAS) reduces ventricular tachycardia risk by altering connexin43</title>
            <link>http://www.medworm.com/index.php?rid=4811944&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F76781n283743426l%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Renin-angiotensin system (RAS) activation is associated with arrhythmias. We investigated the effects of RAS inhibition in
 cardiac-specific angiotensin-converting enzyme (ACE) overexpression (ACE 8/8) mice, which exhibit proclivity to ventricular tachycardia (VT) and sudden death because of reduced connexin43 (Cx43). ACE 8/8 mice were treated with an ACE inhibitor (captopril) or an angiotensin receptor type-1 blocker (losartan). Subsequently, electrophysiological
 studies were performed, and the hearts were extracted for Cx43 quantification using immunoblotting, immunohistochemistry,
 fluorescent dye spread method, and sodium current quantification using whole cell patch clamping. VT was induced in 12.5%
 of captopril-treated ACE 8/8 and in 28.6% of losartan-treated mi...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4811944</comments>
            <pubDate>Fri, 06 May 2011 16:15:09 +0100</pubDate>
            <guid isPermaLink="false">4811944</guid>        </item>
        <item>
            <title>Emerging roles for the BAI1 protein family in the regulation of phagocytosis, synaptogenesis, neurovasculature, and tumor development</title>
            <link>http://www.medworm.com/index.php?rid=4752926&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fx266wu073x2g6771%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;While G-protein-coupled receptors (GPCRs) have received considerable attention for their biological activity in a diversity
 of physiological functions and have become targets for therapeutic intervention in many diseases, the function of the cell
 adhesion subfamily of GPCRs remains poorly understood. Within this group, the family of brain angiogenesis inhibitor molecules
 (BAI1-3) has become increasingly appreciated for their diverse roles in biology and disease. In particular, recent findings
 suggest emerging roles for BAI1 in the regulation of phenomena including phagocytosis, synaptogenesis, and the inhibition
 of tumor growth and angiogenesis via the processing of its extracellular domain into secreted vasculostatins. Here we summarize
 the known biological featu...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4752926</comments>
            <pubDate>Thu, 21 Apr 2011 06:12:41 +0100</pubDate>
            <guid isPermaLink="false">4752926</guid>        </item>
        <item>
            <title>Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism</title>
            <link>http://www.medworm.com/index.php?rid=4744636&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7804683h867134v8%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Lafora disease is a fatal autosomal recessive form of progressive myoclonus epilepsy. Patients manifest myoclonus and tonic–clonic
 seizures, visual hallucinations, intellectual, and progressive neurologic deterioration beginning in adolescence. The two
 genes known to be involved in Lafora disease are EPM2A and NHLRC1 (EPM2B). The EPM2A gene encodes laforin, a dual-specificity protein phosphatase, and the NHLRC1 gene encodes malin, an E3-ubiquitin ligase. The two proteins interact with each other and, as a complex, are thought to regulate
 glycogen synthesis. Here, we report three Lafora families with two novel pathogenic mutations (C46Y and L261P) and two recurrent
 mutations (P69A and D146N) in NHLRC1. Investigation of their functional consequences in cultured mamm...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4744636</comments>
            <pubDate>Wed, 20 Apr 2011 06:05:44 +0100</pubDate>
            <guid isPermaLink="false">4744636</guid>        </item>
        <item>
            <title>Peptide-MHC-based nanovaccines for the treatment of autoimmunity: a “one size fits all” approach?</title>
            <link>http://www.medworm.com/index.php?rid=4722951&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fnvn81406tr4628x6%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Nanotechnology offers enormous potential in drug delivery and in vivo imaging. Nanoparticles (NPs), for example, are being
 extensively tested as scaffolds to deliver anti-cancer therapeutics or imaging tags. Our recent work, discussed herein, indicates
 that an opportunity exists to use NPs to deliver ligands for, and trigger, cognate receptors on T lymphocytes as a way to
 induce therapeutic immune responses in vivo. Specifically, systemic delivery of NPs coated with Type 1 diabetes (T1D)-relevant
 peptide-major histocompatibility complex molecules triggered the expansion of cognate memory autoregulatory (disease-suppressing)
 T cells, suppressed the progression of autoimmune attack against insulin-producing beta cells, and restored glucose homeostasis.
 This therapeu...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4722951</comments>
            <pubDate>Fri, 15 Apr 2011 15:47:14 +0100</pubDate>
            <guid isPermaLink="false">4722951</guid>        </item>
        <item>
            <title>Ultrapotent effects of salvinorin A, a hallucinogenic compound from Salvia divinorum, on LPS-stimulated murine macrophages and its anti-inflammatory action in vivo</title>
            <link>http://www.medworm.com/index.php?rid=4722950&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxl15845408268911%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The hallucinogenic compound, salvinorin A, is a potent κ-opioid receptor (KOR) agonist. However, other target(s) than the
 KOR, such as the cannabinoid CB1 receptor, have been proposed to explain its multiple pharmacological actions. Here, we have
 evaluated the effect of salvinorin A in lipopolysaccharide (LPS)-stimulated macrophages as well as in models of inflammation
 in vivo. Salvinorin A (0.1–10&amp;nbsp;pM) reduced LPS-stimulated nitrite, TNF-α and IL-10 (but not IL-1β) levels as well as iNOS (but
 not COX-2) LPS-induced hyperexpression. The effect of salvinorin A on nitrite levels was reverted by the opioid antagonist
 naloxone, the KOR antagonist nor-binaltorphimine and by the CB1 antagonist rimonabant Salvinorin A also prevented KOR and
 CB1 hyperexpression i...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4722950</comments>
            <pubDate>Fri, 15 Apr 2011 15:47:14 +0100</pubDate>
            <guid isPermaLink="false">4722950</guid>        </item>
        <item>
            <title>Fibrocyte-like cells recruited to the spleen support innate and adaptive immune responses to acute injury or infection</title>
            <link>http://www.medworm.com/index.php?rid=4722953&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fm74l060884175055%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Bone marrow (BM)-derived fibrocytes are a population of CD45+ and collagen Type I-expressing cells that migrate to the spleen and to target injured organs, such as skin, lungs, kidneys,
 and liver. While CD45+Col+ fibrocytes contribute to collagen deposition at the site of injury, the role of CD45+Col+ cells in spleen has not been elucidated. Here, we demonstrate that hepatotoxic injury (CCl4), TGF-β1, lipopolysaccharide, or infection with Listeria monocytogenes induce rapid recruitment of CD45+Col+ fibrocyte-like cells to the spleen. These cells have a gene expression pattern that includes antimicrobial factors (myleoperoxidase,
 cathelicidin, and defensins) and MHC II at higher levels than found on quiescent or activated macrophages. The immune functions
 of these sp...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4722953</comments>
            <pubDate>Fri, 15 Apr 2011 15:47:11 +0100</pubDate>
            <guid isPermaLink="false">4722953</guid>        </item>
        <item>
            <title>Aging impairs the mobilization and homing of bone marrow-derived angiogenic cells to burn wounds</title>
            <link>http://www.medworm.com/index.php?rid=4722952&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmq10778w06037776%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Impaired wound healing in the elderly represents a major clinical problem. Delineating the cellular and molecular mechanisms
 by which aging impairs wound healing may lead to the development of improved treatment strategies for elderly patients with
 non-healing wounds. Neovascularization is an essential step in wound healing, and bone marrow-derived angiogenic cells (BMDACs)
 play an important role in vascularization. Using a mouse full-thickness burn wound model, we demonstrate that perfusion and
 vascularization of burn wounds were impaired by aging and were associated with dramatically reduced mobilization of BMDACs
 bearing the cell surface molecules CXCR4 and Sca1. Expression of stromal-derived factor 1 (SDF-1), the cytokine ligand for
 CXCR4, was significantly de...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4722952</comments>
            <pubDate>Fri, 15 Apr 2011 15:47:11 +0100</pubDate>
            <guid isPermaLink="false">4722952</guid>        </item>
        <item>
            <title>Cytokine toxicity in insulin-producing cells is mediated by nitro-oxidative stress-induced hydroxyl radical formation in mitochondria</title>
            <link>http://www.medworm.com/index.php?rid=4722954&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv1k617mv30532107%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Although nitric oxide (NO) and oxidative stress both contribute to proinflammatory cytokine toxicity in pancreatic β-cells
 during type 1 diabetes mellitus (T1DM) development, the interactions between NO and reactive oxygen species (ROS) in cytokine-mediated
 β-cell death have not been clarified. Exposure of insulin-producing RINm5F cells to IL-1β generated NO, while exposure to
 a combination of IL-1β, TNF-α, and IFN-γ, which simulates T1DM conditions, generated both NO and ROS. In theory, two reactions
 between NO and ROS are possible, one with the superoxide radical yielding peroxynitrite, and the other with hydrogen peroxide
 (H2O2) yielding hydroxyl radicals. Results of the present work exclude peroxynitrite involvement in cytokine toxicity to β-cells
 becau...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4722954</comments>
            <pubDate>Tue, 12 Apr 2011 21:30:14 +0100</pubDate>
            <guid isPermaLink="false">4722954</guid>        </item>
        <item>
            <title>The endothelium-derived contracting factor uridine adenosine tetraphosphate induces P2Y2-mediated pro-inflammatory signaling by monocyte chemoattractant protein-1 formation</title>
            <link>http://www.medworm.com/index.php?rid=4722955&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl632683g44817130%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;It is very well established that purinergic signaling plays a relevant role in vascular physiology and pathophysiology. Recently,
 a new purinoceptor agonist uridine adenosine tetraphosphate (Up4A) has been identified as a highly potent endothelial-derived contracting factor (EDCF). The purpose of the study was to investigate
 Up4A's influence on pro-inflammatory mechanisms. An early component of the inflammatory response in atherogenesis is the oxidative
 stress-induced formation of monocyte chemoattractant protein-1 (MCP-1). Here, we investigated the influence of Up4A on MCP-1 formation and characterized the underlying signaling transduction mechanisms in rat vascular smooth muscle cells
 (VSMCs). Up4A induced MCP-1 expression and secretion in VSMCs via the activation...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4722955</comments>
            <pubDate>Tue, 12 Apr 2011 21:30:13 +0100</pubDate>
            <guid isPermaLink="false">4722955</guid>        </item>
        <item>
            <title>Proteomic identification of RhoA as a potential biomarker for proliferation and metastasis in hepatocellular carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=4696040&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fxv0g057368uk0564%2F</link>
            <description>In this study, highly purified
 plasma membrane proteins from clinical tissue samples were obtained using a strategy combining sucrose density gradient centrifugation
 and subsequent phase partition. Using a two-dimensional gel electrophoresis and MALDI-Q-TOF MS/MS-based proteomics approach,
 we identified 13 plasma membrane-associated proteins that were differentially expressed in HCC and normal liver tissues. Of
 those, RhoA was one of the most significantly upregulated proteins in HCC, and its overexpression was confirmed using Western
 blotting. Immunohistochemistry suggested a link between RhoA expression and poor differentiation and clinicopathologic stage.
 Suppression of RhoA expression in HepG2 and Hep3B cells by RNA interference led to significant inhibition of cell growth,
 indu...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4696040</comments>
            <pubDate>Thu, 07 Apr 2011 17:09:25 +0100</pubDate>
            <guid isPermaLink="false">4696040</guid>        </item>
        <item>
            <title>Growth differentiation factor 15 in patients with congenital dyserythropoietic anaemia (CDA) type II</title>
            <link>http://www.medworm.com/index.php?rid=4696041&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn39277p8x634563w%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Congenital dyserythropoietic anaemias (CDAs) are heterogeneous, hereditary disorders hallmarked by ineffective erythropoiesis
 and tissue iron overload. Growth differentiation factor 15 (GDF15) was suggested to mediate iron overload in iron-loading
 anaemias, such as the thalassaemias and CDAI by suppressing hepcidin, the key regulator of iron absorption. Here, we show
 that serum GDF15 concentrations are elevated in subjects with CDAI and CDAII. Despite similar disease characteristics, CDAI
 patients present with significantly higher GDF15 concentrations compared to CDAII patients. Hepcidin concentrations are inappropriately
 low in CDAII patients considering the severe hepatic iron overload associated with this disorder. GDF15 significantly correlates
 with the degree...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4696041</comments>
            <pubDate>Thu, 07 Apr 2011 17:09:24 +0100</pubDate>
            <guid isPermaLink="false">4696041</guid>        </item>
        <item>
            <title>The fatty acid translocase CD36 could be burden at life’s winter</title>
            <link>http://www.medworm.com/index.php?rid=4696042&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv4766883585005j7%2F</link>
            <description>Content Type Journal ArticlePages 1-3DOI 10.1007/s00109-011-0755-1Authors
		Friedrich Luft, Experimental and Clinical Research Center, Charité Medical Faculty and Max-Delbrück Center for Molecular Medicine, Robert-Rössle Strasse 10, 13125 Berlin, Germany
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4696042</comments>
            <pubDate>Thu, 07 Apr 2011 17:09:23 +0100</pubDate>
            <guid isPermaLink="false">4696042</guid>        </item>
        <item>
            <title>Ursolic acid inhibits multiple cell survival pathways leading to suppression of growth of prostate cancer xenograft in nude mice</title>
            <link>http://www.medworm.com/index.php?rid=4692509&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcn67x7j7l54l0451%2F</link>
            <description>In this study, we investigated the effect of ursolic acid (UA) on NF-κB and STAT3 signaling pathways in both androgen-independent
 (DU145) and androgen-dependent (LNCaP) prostate cancer cell lines and also prospectively tested the hypothesis of NF-κB and
 STAT3 inhibition using a virtual predictive functional proteomics tumor pathway technology platform. We found that UA inhibited
 constitutive and TNF-α-induced activation of NF-κB in DU145 and LNCaP cells in a dose-dependent manner. The suppression was
 mediated through the inhibition of constitutive and TNF-α-induced IκB kinase (IKK) activation, phosphorylation of IκBα and
 p65 and NF-κB-dependent reporter activity. Furthermore, UA suppressed both constitutive and inducible STAT3 activation in
 prostate cancer cells concomitant ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4692509</comments>
            <pubDate>Tue, 05 Apr 2011 09:58:29 +0100</pubDate>
            <guid isPermaLink="false">4692509</guid>        </item>
        <item>
            <title>Erratum to: Metabolic regulation by p53</title>
            <link>http://www.medworm.com/index.php?rid=4663232&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0703h7u611074684%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00109-011-0745-3Authors
		Oliver D. K. Maddocks, The Beatson Institute for Cancer Research, Switchback Road, Glasgow, G61 1BD UKKaren H. Vousden, The Beatson Institute for Cancer Research, Switchback Road, Glasgow, G61 1BD UK
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4663232</comments>
            <pubDate>Tue, 29 Mar 2011 17:34:59 +0100</pubDate>
            <guid isPermaLink="false">4663232</guid>        </item>
        <item>
            <title>RANKL/RANK—beyond bones</title>
            <link>http://www.medworm.com/index.php?rid=4663233&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fr53v6v889060v750%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Receptor-activator of NF-κB ligand (TNFSF11, also known as RANKL, OPGL, TRANCE, and ODF) and its tumor necrosis factor (TNF)-family
 receptor RANK are essential regulators of bone remodeling, lymph node formation, establishment of the thymic microenvironment,
 mammary gland development during pregnancy, and bone metastasis in cancer. We have recently also reported that the RANKL/RANK
 system controls the incidence and onset of sex hormone, progestin-driven breast cancer. RANKL and RANK are also expressed
 in the central nervous systems where they play an essential role in body temperature regulation. RANKL activates brain regions
 involved in thermoregulation and induces fever via the COX2-PGE2/EP3R pathway. Moreover, female mice with a RANK gene deleted in neurons and...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4663233</comments>
            <pubDate>Tue, 29 Mar 2011 06:03:00 +0100</pubDate>
            <guid isPermaLink="false">4663233</guid>        </item>
        <item>
            <title>Novel splice variant CAR 4/6 of the coxsackie adenovirus receptor is differentially expressed in cervical carcinogenesis</title>
            <link>http://www.medworm.com/index.php?rid=4635886&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F8x4253501jm82823%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The coxsackie adenovirus receptor (CAR) is a component of the tight junction complex and involved in cell adhesion. Loss of
 CAR expression can affect cell adhesion which in the context of carcinogenesis may influence both invasion and metastatic
 spread. Functional inactivation of CAR may also result from the interaction with its soluble isoforms. To relate alterations
 of CAR expression to tumor progression, we aimed to establish a highly specific real-time PCR protocol for quantification
 of all splice variants. In the process of cloning, we identified a novel splice variant termed CAR4/6 that lacked exon 5 but
 retained exon 6 encoding the transmembrane domain. Localization of CAR4/6 in the cell membrane was confirmed by ectopic expression
 in HT1080 cells. Expressi...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4635886</comments>
            <pubDate>Tue, 22 Mar 2011 18:09:49 +0100</pubDate>
            <guid isPermaLink="false">4635886</guid>        </item>
        <item>
            <title>AMP-activated protein kinase inhibits NF-κB signaling and inflammation: impact on healthspan and lifespan</title>
            <link>http://www.medworm.com/index.php?rid=4635887&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fyn0770q85vk50v48%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Adenosine monophosphate-activated protein kinase (AMPK) is a crucial regulator of energy metabolic homeostasis and thus a
 major survival factor in a variety of metabolic stresses and also in the aging process. Metabolic syndrome is associated with
 a low-grade, chronic inflammation, primarily in adipose tissue. A low-level of inflammation is also present in the aging process.
 There are emerging results indicating that AMPK signaling can inhibit the inflammatory responses induced by the nuclear factor-κB
 (NF-κB) system. The NF-κB subunits are not direct phosphorylation targets of AMPK, but the inhibition of NF-κB signaling is
 mediated by several downstream targets of AMPK, e.g., SIRT1, PGC-1α, p53, and Forkhead box O (FoxO) factors. AMPK signaling
 seems to enha...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4635887</comments>
            <pubDate>Tue, 22 Mar 2011 18:09:48 +0100</pubDate>
            <guid isPermaLink="false">4635887</guid>        </item>
        <item>
            <title>Increased CD36 expression in middle-aged mice contributes to obesity-related cardiac hypertrophy in the absence of cardiac dysfunction</title>
            <link>http://www.medworm.com/index.php?rid=4577743&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F0366x23048670733%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;As aging is a significant risk factor for the development of left ventricular hypertrophy and cardiovascular disease, we hypothesized
 that hearts from middle-aged mice may be more sensitive to the effects of a high fat (HF) diet than hearts from young mice.
 To investigate this, young (10–12&amp;nbsp;week old) and middle-aged (40–44&amp;nbsp;week old) male mice were fed a low fat (LF) or HF diet
 (10 or 60&amp;nbsp;kcal% fat, respectively) for 12&amp;nbsp;weeks. Following this 12-week period, we show that CD36 protein expression was not
 changed in hearts from young mice yet was increased 1.5-fold in the middle-aged HF group compared with LF-fed age-matched
 counterparts. Correlated with increased CD36 expression, middle-aged mice displayed a greater degree of cardiac hypertrophy
...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4577743</comments>
            <pubDate>Wed, 09 Mar 2011 07:01:02 +0100</pubDate>
            <guid isPermaLink="false">4577743</guid>        </item>
        <item>
            <title>Neutralization of LPS or blockage of TLR4 signaling prevents stress-triggered fetal loss in murine pregnancy</title>
            <link>http://www.medworm.com/index.php?rid=4577742&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F840415pp8t487126%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Maternal stress can cause loss of both histocompatible (syngeneic) and histoincompatible (semiallogeneic) embryos in pregnant
 mice. Stress increases abortogenic Th1 cytokines and reduces levels of anti-abortogenic Th2 cytokines, progesterone levels,
 and T regulatory cell activity. While physiological levels of interferon-γ promote vascular remodeling at the feto-maternal
 interface, an overshooting Th1 cytokine response requires a Toll-like receptor (TLR)-mediated “danger signal” such as lipopolysaccharide
 (LPS). Interestingly, stress can enhance permeability of mucosal membranes to entry of bacterial products and promote transmucosal
 migration of commensal bacteria. We hypothesized that bacterial component such as LPS may provide the danger signal through
 whi...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4577742</comments>
            <pubDate>Wed, 09 Mar 2011 07:01:02 +0100</pubDate>
            <guid isPermaLink="false">4577742</guid>        </item>
        <item>
            <title>A peptide binding to dimerized translationally controlled tumor protein modulates allergic reactions</title>
            <link>http://www.medworm.com/index.php?rid=4565262&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe2px5181q887hk34%2F</link>
            <description>This study suggests
 that the dTBP2 binding to dTCTP modulates the release of inflammatory mediators of dTCTP. This result may provide a rational
 strategy for the treatment of allergic diseases.
 
 
	Content Type Journal ArticlePages 1-8DOI 10.1007/s00109-011-0740-8Authors
		Miyoung Kim, College of Pharmacy, Center for Cell Signalling &amp; Drug Discovery Research, Ewha Womans University, Seoul, 120–750 South KoreaJunho Chung, College of Medicine and Cancer Research Institute, Seoul National University, Seoul, 110–799 South KoreaChulhee Lee, Department of Otorhinolaryngology–Head and Neck Surgery, Seoul National University College of Medicine, Seoul, 110–799 South KoreaJaehoon Jung, College of Pharmacy, Center for Cell Signalling &amp; Drug Discovery Research, Ewha Womans University, Seou...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4565262</comments>
            <pubDate>Mon, 07 Mar 2011 17:02:36 +0100</pubDate>
            <guid isPermaLink="false">4565262</guid>        </item>
        <item>
            <title>VEGF non-angiogenic functions in adult organ homeostasis: therapeutic implications</title>
            <link>http://www.medworm.com/index.php?rid=4549322&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk64pt41m2816t126%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Vascular endothelial growth factor (VEGF) is best known as an angiogenic factor essential for embryonic vasculogenesis and
 postnatal angiogenesis. Considerable evidence has accumulated that VEGF also has non-angiogenic functions. Early studies demonstrated
 that VEGF transcripts are ubiquitously expressed, and the phosphorylation of VEGF receptor is detectable in adult organs that
 have no feature of angiogenesis. Recent clinical studies showed that the inhibition of VEGF signaling results in diverse angiogenesis-irrelevant
 side effects involving the dysfunctions of many organs, suggesting non-angiogenic roles of VEGF in the regulation of organ
 homeostasis. On the other hand, VEGF stimulates endothelial cells (ECs) to express intercellular adhesion molecules that med...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4549322</comments>
            <pubDate>Wed, 02 Mar 2011 06:57:35 +0100</pubDate>
            <guid isPermaLink="false">4549322</guid>        </item>
        <item>
            <title>The nutraceutical flavonoid luteolin inhibits ADAMTS-4 and ADAMTS-5 aggrecanase activities</title>
            <link>http://www.medworm.com/index.php?rid=4549323&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F36231445583qpp58%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;A disintegrin and metalloprotease with thrombospondin domains (ADAMTS)-4 (aggrecanase-1) and ADAMTS-5 (aggrecanase-2) are
 metalloproteases involved in articular cartilage degradation and represent potential therapeutic targets in arthritis treatment.
 We explore herein the ability of different natural compounds to specifically block the destructive action of these enzymes.
 Following a preliminary screening using carboxymethylated transferrin as substrate, we focused our interest on luteolin due
 to its inhibitory effect on ADAMTS-4 and ADAMTS-5 activities using aggrecan and fluorogenic peptides as substrates. However,
 matrix metalloproteinases (MMPs) activities on these substrates result less affected by this flavonoid. Moreover, incubation
 of mouse chondrogenic ATD...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4549323</comments>
            <pubDate>Wed, 02 Mar 2011 06:57:33 +0100</pubDate>
            <guid isPermaLink="false">4549323</guid>        </item>
        <item>
            <title>Molecular analysis of 51 unrelated pedigrees with late-onset multiple acyl-CoA dehydrogenation deficiency (MADD) in southern China confirmed the most common ETFDH mutation and high carrier frequency of c.250G&gt;A</title>
            <link>http://www.medworm.com/index.php?rid=4540025&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fk24m037mj5x8v56g%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Multiple acyl-CoA dehydrogenation deficiency (MADD) is an autosomal recessive disease affecting amino acid, fatty acid, and
 choline metabolisms and is a common genetic defect responsible for lipid storage myopathy. Most forms of MADD are caused by
 a deficiency of electron transfer flavoprotein (ETF) or ETF dehydrogenase (ETFDH). However, its molecular feature has not
 been found uniformly in previous reports of Chinese patients. A large cohort of 56 late-onset MADD patients from 51 unrelated
 pedigrees in southern China was recruited to investigate a clear correlation between clinical phenotype and molecular genetic
 basis. All exons of ETFA, ETFB, and ETFDH, including the intron–exon boundaries, and 5′ and 3′ untranslated regions were directly sequenced. ETFDH ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4540025</comments>
            <pubDate>Wed, 23 Feb 2011 23:14:26 +0100</pubDate>
            <guid isPermaLink="false">4540025</guid>        </item>
        <item>
            <title>Erratum to: TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functional DR5</title>
            <link>http://www.medworm.com/index.php?rid=4574671&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj2002p1057h97587%2F</link>
            <description>Content Type Journal ArticlePages 423-423DOI 10.1007/s00109-011-0738-2Authors
		Johannes Lemke, Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Arnold-Heller Str. 3, Haus 17, 24 105 Kiel, GermanyAndreas Noack, Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Arnold-Heller Str. 3, Haus 17, 24 105 Kiel, GermanyDieter Adam, Institute of Immunology, UK S-H, Kiel, GermanyVladimir Tchikov, Institute of Immunology, UK S-H, Kiel, GermanyUwe Bertsch, Institute of Immunology, UK S-H, Kiel, GermanyChristian Röder, Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Arnold-Heller Str. 3, Haus 17, ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4574671</comments>
            <pubDate>Wed, 23 Feb 2011 23:14:24 +0100</pubDate>
            <guid isPermaLink="false">4574671</guid>        </item>
        <item>
            <title>Erratum to: TRAIL signaling is mediated by DR4 in pancreatic tumor cells despite the expression of functionalDR5</title>
            <link>http://www.medworm.com/index.php?rid=4540026&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fj2002p1057h97587%2F</link>
            <description>Content Type Journal ArticlePages 1-1DOI 10.1007/s00109-011-0738-2Authors
		Johannes Lemke, Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Arnold-Heller Str. 3, Haus 17, 24 105 Kiel, GermanyAndreas Noack, Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Arnold-Heller Str. 3, Haus 17, 24 105 Kiel, GermanyDieter Adam, Institute of Immunology, UK S-H, Kiel, GermanyVladimir Tchikov, Institute of Immunology, UK S-H, Kiel, GermanyUwe Bertsch, Institute of Immunology, UK S-H, Kiel, GermanyChristian Röder, Division of Molecular Oncology, Institute of Experimental Cancer Research, Comprehensive Cancer Center North, UK S-H, Arnold-Heller Str. 3, Haus 17, 24 1...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4540026</comments>
            <pubDate>Wed, 23 Feb 2011 23:14:24 +0100</pubDate>
            <guid isPermaLink="false">4540026</guid>        </item>
        <item>
            <title>Use of ginseng to reduce post-myocardial adverse myocardial remodeling: applying scientific principles to the use of herbal therapies</title>
            <link>http://www.medworm.com/index.php?rid=4511653&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F288gk16372k7u024%2F</link>
            <description>Content Type Journal ArticlePages 1-4DOI 10.1007/s00109-011-0736-4Authors
		Sreedhar Bodiga, Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta T6G 2S2, CanadaWang Wang, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, CanadaGavin Y. Oudit, Division of Cardiology, Department of Medicine, Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta T6G 2S2, Canada
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4511653</comments>
            <pubDate>Mon, 21 Feb 2011 17:06:58 +0100</pubDate>
            <guid isPermaLink="false">4511653</guid>        </item>
        <item>
            <title>Hypoxia: a double-edged sword of immunity</title>
            <link>http://www.medworm.com/index.php?rid=4511654&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F447u5117k5jx4264%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Hypoxia is a condition of low oxygen tension that characterizes virtually every site of inflammation, tissue damage, and neoplasia.
 Hypoxic environment attracts infiltrating immune cells that move against oxygen gradients and respond to these demanding conditions
 by switching to anaerobic metabolism to maintain their energy requirements. Several lines of evidence suggest that oxygen
 deprivation causes opposite effects on the innate or adaptive immune responses. We will review the evidence that the hypoxic
 environment promotes the recruitment, activation, and survival of innate immune cells while inhibiting the adaptive immunity
 through downregulation of effector lymphocyte functions. This divergent regulation of the innate and adaptive immunity appears
 to reflect ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4511654</comments>
            <pubDate>Sat, 19 Feb 2011 07:05:30 +0100</pubDate>
            <guid isPermaLink="false">4511654</guid>        </item>
        <item>
            <title>Low amounts of PHOX2B expanded alleles in asymptomatic parents suggest unsuspected recurrence risk in congenital central hypoventilation syndrome</title>
            <link>http://www.medworm.com/index.php?rid=4511655&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fb7xg55747730m365%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Heterozygous trinucleotide in frame duplications, leading to expansions of variable lengths of a 20-alanine stretch (polyAla),
 is the most frequent PHOX2B variant associated with congenital central hypoventilation syndrome (CCHS), a rare neurocristopathy characterized by defective
 response of the autonomic nervous system to hypoxia and hypercapnia. Sequencing analysis has shown that the vast majority
 of polyAla expansions arise de novo; while in about 10% of cases, mutations are inherited by one parent who carries either
 constitutive or somatic mutations. To investigate transmission of PHOX2B mutant alleles from asymptomatic individuals, we have reassessed 44 parental pairs, previously resulted not to carry any
 mutation, by coupling amplification with FAM-tagged pr...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4511655</comments>
            <pubDate>Sat, 19 Feb 2011 07:05:27 +0100</pubDate>
            <guid isPermaLink="false">4511655</guid>        </item>
        <item>
            <title>Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability</title>
            <link>http://www.medworm.com/index.php?rid=4501099&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F01r7444282g78746%2F</link>
            <description>This study was
 performed to investigate whether epigallocatechin-3-gallate (EGCG), the major constituent of green tea, interacted with sunitinib.
 The interaction between EGCG and sunitinib was examined in vitro and in vivo. 1H nuclear magnetic resonance (1H-NMR) spectroscopy and mass spectrometry (MS) were used to analyze the interaction between these two molecules and whether
 a new compound was formed. Solutions of sunitinib and EGCG were intragastrically administered to rats to investigate whether
 the plasma concentrations of sunitinib were affected by EGCG. In this study, we noticed that a precipitate was formed when
 the solutions of sunitinib and EGCG were mixed under both neutral and acidic conditions. 1H-NMR spectra indicated an interaction between EGCG and sunitinib, but no new...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4501099</comments>
            <pubDate>Thu, 17 Feb 2011 17:02:54 +0100</pubDate>
            <guid isPermaLink="false">4501099</guid>        </item>
        <item>
            <title>Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction</title>
            <link>http://www.medworm.com/index.php?rid=4494431&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl381472784k85903%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Ginsenoside-Rg1 (Rg1) has been used in the traditional Chinese medicine for over 2,000&amp;nbsp;years. The present study was performed
 to test our hypothesis that Rg1 provides pro-angiogenic and anti-fibrotic benefits in the ischemic myocardium in a rat model
 of myocardial infarction. The expression of vascular endothelial growth factor (VEGF) and phosphorylation/activation of PI3K,
 Akt, and p38 MAPK signaling pathways were examined in human umbilical vein endothelial cells and in the myocardial samples
 of rats. In addition, the expression levels of TNF-α and collagen I level, the number of newly formed blood vessels, the extent
 of myocardial fibrosis, and left ventricular function were measured in vivo. Our results demonstrated that administration
 of Rg1 increased V...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4494431</comments>
            <pubDate>Wed, 16 Feb 2011 06:58:17 +0100</pubDate>
            <guid isPermaLink="false">4494431</guid>        </item>
        <item>
            <title>Critical role of proteostasis-imbalance in pathogenesis of COPD and severe emphysema</title>
            <link>http://www.medworm.com/index.php?rid=4488782&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fh3077753lw797wk1%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The environmental, genetic, and/or age-related changes in proteostasis induce inflammation, oxidative stress, and apoptosis.
 We quantified the correlation of protein expression of critical proteostasis mediators to severity of chronic lung disease
 using lung tissue samples from control and chronic obstructive pulmonary disease (COPD) subjects (GOLD stage 0–IV) and cigarette
 smoke (CS)-induced murine model. The human bronchial epithelial cells, HEK-293, and Beas2B cells were used for in vitro experiments
 to verify the mechanisms. Our data verifies the correlation of higher expression of valosin-containing protein (VCP) retrograde
 translocation complex (VCP-Rma1-gp78) with severity of emphysema in COPD lung tissues and over-expression of inflammatory,
 ER stress an...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4488782</comments>
            <pubDate>Fri, 11 Feb 2011 11:49:41 +0100</pubDate>
            <guid isPermaLink="false">4488782</guid>        </item>
        <item>
            <title>A return to cancer metabolism</title>
            <link>http://www.medworm.com/index.php?rid=4459229&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fym378q658153136j%2F</link>
            <description>Content Type Journal ArticlePages 1-2DOI 10.1007/s00109-011-0733-7Authors
		Gregg L. Semenza, Vascular Program, Institute for Cell Engineering; Departments of Pediatrics, Medicine, Oncology, Radiation Oncology, Biological Chemistry, and the McKusick-Nathans Institute of Genetic Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD USA
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4459229</comments>
            <pubDate>Mon, 07 Feb 2011 22:41:20 +0100</pubDate>
            <guid isPermaLink="false">4459229</guid>        </item>
        <item>
            <title>Therapeutic targeting of cancer cell metabolism</title>
            <link>http://www.medworm.com/index.php?rid=4459230&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F7261p31264508t41%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;In 1927, Otto Warburg and coworkers reported the increased uptake of glucose and production of lactate by tumors in vivo as
 compared with normal tissues. This phenomenon, now known as the Warburg effect, was recapitulated in vitro with cancer tissue
 slices exhibiting excessive lactate production even with adequate oxygen. Warburg's in vivo studies of tumors further suggest
 that the dependency of tumors in vivo on glucose could be exploited for therapy, because reduction of arterial glucose by
 half resulted in a four-fold reduction in tumor fermentation. Recent work in cancer metabolism indicates that the Warburg
 effect or aerobic glycolysis contributes to redox balance and lipid synthesis, but glycolysis is insufficient to sustain a
 growing and dividing cancer cel...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4459230</comments>
            <pubDate>Mon, 07 Feb 2011 22:41:15 +0100</pubDate>
            <guid isPermaLink="false">4459230</guid>        </item>
        <item>
            <title>The Gretchen question in autosomal-dominant polycystic kidney disease research</title>
            <link>http://www.medworm.com/index.php?rid=4459231&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fn66t30458j48h276%2F</link>
            <description>Content Type Journal ArticlePages 1-4DOI 10.1007/s00109-011-0734-6Authors
		Friedrich C. Luft, Experimental and Clinical Research Center, Max-Delbrück Center and Charité Medical Faculty, Lindenbergerweg 80, 13125 Berlin, Germany
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4459231</comments>
            <pubDate>Mon, 07 Feb 2011 22:41:14 +0100</pubDate>
            <guid isPermaLink="false">4459231</guid>        </item>
        <item>
            <title>Glutamine: pleiotropic roles in tumor growth and stress resistance</title>
            <link>http://www.medworm.com/index.php?rid=4459232&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fe56405735x463443%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Tumors and tumor cell lines rapidly consume the amino acid glutamine (Gln) and use it to supply metabolic pathways that support
 cell growth and proliferation. Much of the research regarding the relationship between glutamine metabolism and cancer is
 based on the premise that this abundant nutrient represents an important driver of tumor cell anabolism. However, Gln's influence
 in cell biology and cancer extends far beyond its use as a carbon and nitrogen source for the structural components of dividing
 cells. Gln is truly a multipurpose nutrient, feeding many additional pathways that boost the ability of cells to communicate
 with each other and to cope with stress by oncogenic signaling and by the tumor microenvironment. A number of recent reports
 have highlighted...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4459232</comments>
            <pubDate>Mon, 07 Feb 2011 22:41:13 +0100</pubDate>
            <guid isPermaLink="false">4459232</guid>        </item>
        <item>
            <title>hSMG-1 is a granzyme B-associated stress-responsive protein kinase</title>
            <link>http://www.medworm.com/index.php?rid=4459233&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fw88268847v361212%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Granzyme B plays a key role in cell-mediated programmed cell death. We previously demonstrated that p53 is a functional determinant
 in the granzyme B-induced cytotoxic T-lymphocyte response. However, the pathways leading to activation of p53 by granzyme
 B remain incompletely understood. We now demonstrate that granzyme B-induced DNA damage signaling as revealed by histone H2AX
 phosphorylation and subsequent activation of the stress kinase CHK2. Confocal microscopy analysis indicates that granzyme
 B treatment of tumor cells induced an early translocation of endonuclease caspase-activated DNase. DNA microarray-based global
 transcriptional profiling and RT-PCR indeed revealed genes related to DNA damage. Among these genes, hSMG-1, a genotoxic stress-activated
 protein...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4459233</comments>
            <pubDate>Mon, 07 Feb 2011 22:41:10 +0100</pubDate>
            <guid isPermaLink="false">4459233</guid>        </item>
        <item>
            <title>mTOR links oncogenic signaling to tumor cell metabolism</title>
            <link>http://www.medworm.com/index.php?rid=4459234&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fmj340350lr89jp52%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;As a key regulator of cell growth and proliferation, the mammalian target of rapamycin (mTOR) complex 1 (mTORC1) has been
 the subject of intense investigation for its role in tumor development and progression. This research has revealed a signaling
 network of oncogenes and tumor suppressors lying upstream of mTORC1, and oncogenic perturbations to this network result in
 the aberrant activation of this kinase complex in the majority of human cancers. However, the molecular events downstream
 of mTORC1 contributing to tumor cell growth and proliferation are just coming to light. In addition to its better-known functions
 in promoting protein synthesis and suppressing autophagy, mTORC1 has emerged as a key regulator of cellular metabolism. Recent
 studies have found that...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4459234</comments>
            <pubDate>Mon, 07 Feb 2011 22:41:07 +0100</pubDate>
            <guid isPermaLink="false">4459234</guid>        </item>
        <item>
            <title>Development of S/MAR minicircles for enhanced and persistent transgene expression in the mouse liver</title>
            <link>http://www.medworm.com/index.php?rid=4459236&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv82937t57m551836%2F</link>
            <description>We describe here the development of a minimally sized
 S/MAR vector, which is devoid of extraneous bacterial sequences. This minicircle vector comprises an expression cassette and
 an S/MAR moiety, providing higher and more sustained transgene expression for several months in the absence of selection,
 both in vitro and in vivo. In contrast to the expression of our original S/MAR plasmid vector, the novel S/MAR minicircle
 vectors mediate increased transgene expression, which becomes sustained at about twice the levels observed immediately after
 administration. These promising results demonstrate the utility of minimally sized S/MAR vectors for persistent, atoxic gene
 expression.
 
 
	Content Type Journal ArticlePages 1-15DOI 10.1007/s00109-010-0713-3Authors
		Orestis Argyros, Gene Thera...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4459236</comments>
            <pubDate>Mon, 07 Feb 2011 22:41:04 +0100</pubDate>
            <guid isPermaLink="false">4459236</guid>        </item>
        <item>
            <title>Inborn and acquired metabolic defects in cancer</title>
            <link>http://www.medworm.com/index.php?rid=4459235&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fv694624h31648477%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The observation that altered metabolism is the fundamental cause of cancer was made by Otto Warburg nearly a century ago.
 However, the subsequent identification of oncogenes and tumor suppressor genes has displaced Warburg's theory pointing towards
 genetic aberrations as the underlining cause of cancer. Nevertheless, in the last decade, cancer-associated mutations have
 been identified in genes coding for tricarboxylic acid cycle (TCA cycle, also known as Krebs cycle) and closely related enzymes
 that have essential roles in cellular metabolism. These observations have revived interest in Warburg's hypothesis and prompted
 a flurry of functional studies in the hope of gaining mechanistic insight into the links between mitochondrial dysfunction,
 metabolic alterations,...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4459235</comments>
            <pubDate>Mon, 07 Feb 2011 22:41:04 +0100</pubDate>
            <guid isPermaLink="false">4459235</guid>        </item>
        <item>
            <title>Is CaMKII a link between inflammation and hypertrophy in heart?</title>
            <link>http://www.medworm.com/index.php?rid=4428431&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc3g85001517r4q40%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Myocardial infarction is a major cause of morbidity and mortality in the developing and developed world. Although current
 interventions have been successful in prolonging life, they are inadequate because mortality is still high among MI patients.
 The multifunctional Ca2+/calmodulin-dependent protein kinase (CaMKII) plays a key role in the structure and contractility of the myocardium. CaMKII
 activity is increased in MI hearts and CaMKII promotes cardiac hypertrophy and inflammation, processes consistently activated
 by myocardial injury. Hypertrophy and inflammation are also related to neurohumoral and redox signaling which uncouple CaMKII
 activation from Ca2+/calmodulin dependence. Thus, CaMKII may act as a nodal point for integrating hypertrophic and inflammatory...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4428431</comments>
            <pubDate>Fri, 28 Jan 2011 20:28:25 +0100</pubDate>
            <guid isPermaLink="false">4428431</guid>        </item>
        <item>
            <title>Recent developments in drug-eluting stents</title>
            <link>http://www.medworm.com/index.php?rid=4428430&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fc762245804p86041%2F</link>
            <description>This article reviews recent developments in DES.
 
 
	Content Type Journal ArticlePages 1-9DOI 10.1007/s00109-011-0729-3Authors
		Yue Li, Centre for Vascular Research, University of New South Wales, Sydney, NSW 2052 AustraliaRavinay Bhindi, Department of Cardiology, Royal North Shore Hospital, St Leonards, NSW 2065 Sydney, AustraliaLevon M. Khachigian, Centre for Vascular Research, University of New South Wales, Sydney, NSW 2052 Australia
	

	
		Journal Journal of Molecular MedicineOnline ISSN 1432-1440Print ISSN 0946-2716 (Source: Journal of Molecular Medicine)</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4428430</comments>
            <pubDate>Fri, 28 Jan 2011 20:28:25 +0100</pubDate>
            <guid isPermaLink="false">4428430</guid>        </item>
        <item>
            <title>Regression and stabilization of advanced murine atherosclerotic lesions: a comparison of LDL lowering and HDL raising gene transfer strategies</title>
            <link>http://www.medworm.com/index.php?rid=4404915&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fcq546211p713631v%2F</link>
            <description>In conclusion, drastic lipid lowering induced by a powerful gene transfer strategy
 leads to pronounced regression and stabilization of advanced murine atherosclerosis.
 
 
	Content Type Journal ArticlePages 1-13DOI 10.1007/s00109-011-0722-xAuthors
		Eline Van Craeyveld, Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, BelgiumStephanie C. Gordts, Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, BelgiumElena Nefyodova, Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven, BelgiumFrank Jacobs, Center for Molecular and Vascular Biology, University of Leuven, Campus Gasthuisberg, Herestraat 49, 3000 Leuven,...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4404915</comments>
            <pubDate>Thu, 20 Jan 2011 07:06:59 +0100</pubDate>
            <guid isPermaLink="false">4404915</guid>        </item>
        <item>
            <title>MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs</title>
            <link>http://www.medworm.com/index.php?rid=4355301&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2Fl7w178680kr0r010%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;The management of tumor cell invasion and metastasis is instrumental in cancer therapy, since metastases are the prime reason
 for cancer patient mortality. Various cellular mechanisms and underlying molecular pathways relevant for metastasis have been
 identified so far, providing a basis for antimetastatic drugs. MicroRNAs (miRNAs) are highly conserved, small noncoding RNA
 molecules that have been shown to regulate various cellular processes by interfering with protein expression through posttranscriptional
 repression or mRNA degradation. More importantly, beyond their roles in physiological processes, many miRNAs are aberrantly
 expressed in various pathologies including cancer and regulate tumor- and metastasis-associated genes. Their pivotal role
 in metastasis h...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355301</comments>
            <pubDate>Fri, 14 Jan 2011 16:41:49 +0100</pubDate>
            <guid isPermaLink="false">4355301</guid>        </item>
        <item>
            <title>Temperature-sensitive bacterial pathogens generated by the substitution of essential genes from cold-loving bacteria: potential use as live vaccines</title>
            <link>http://www.medworm.com/index.php?rid=4355302&amp;cid=s_33358_67_f&amp;fid=33358&amp;url=http%3A%2F%2Fwww.springerlink.com%2Fcontent%2F32qwm067nt64651n%2F</link>
            <description>Abstract&amp;nbsp;&amp;nbsp;Temperature-sensitive (TS) viruses have been used for decades as vaccines capable of limited replication in their hosts. Although
 attenuated bacteria, such as the Bacille Calmette–Guérin anti-tuberculosis vaccine, have been used for almost a century, it
 is only recently that there has been progress in using TS bacterial strains as live vaccines. Decades of work on essential
 bacterial genes and the recent explosion in the number of available bacterial genomic sequences set the groundwork for the
 identification of essential genes from diverse bacteria. This knowledge has allowed for the substitution of essential genes
 from cold-loving bacteria into the chromosomes of pathogenic bacteria. Many of these gene substitutions generated TS pathogenic
 bacterial strains, ...</description>
            <author>Journal of Molecular Medicine</author>
            <type>journals</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4355302</comments>
            <pubDate>Wed, 12 Jan 2011 17:04:55 +0100</pubDate>
            <guid isPermaLink="false">4355302</guid>        </item>
    </channel>
</rss>

